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Zusammenfassung 
Die NF-!B Signalkaskade stellt eine Verbindung zwischen Entzündungsprozessen 
und Krebs dar. Der NF-!B Signalweg wird durch Stress-assoziierte Reize wie 
Pathogen-assoziierte Molekulare Muster (PAMPs), inflammatorische Zytokine und 
UV-Licht initiiert. Da die Aktivierung dieses Signalweges zur Expression von anti-
apoptotischen Molekülen, inflammatorischen Signalkomponenten, sowie anti-
bakteriellen Peptiden führt, stellt NF-!B einen zentralen Regulator von entzündlichen 
Prozessen dar. Darüber hinaus weisen verschiedene Krebsarten eine erhöhte NF-!B 
Aktivität auf, die sich nicht nur auf Tumor-infiltrierende Immunzellen beschränkt, 
sondern auch in den Krebszellen selber aufzufinden ist. Es wird vermutet, dass die 
Wirkung von NF-!B in Tumorzellen den Zelltod verhindert und die Zellproliferation 
fördert. Dahingegen induziert NF-!B in Zellen des Immunsystems die Sekretion von 
Zytokinen und Wachstumsfaktoren, wodurch Tumorwachstum und Angiogenese 
gefördert werden. Allerdings ist bisher nicht geklärt worden, ob die Aktivierung von 
NF-!B die Entstehung von Tumoren durch zellinterne Tumor-fördernde Wirkungen in 
nicht transformierten Zellen zu initiieren vermag. In dieser Arbeit wird gezeigt, dass 
die Expression einer konstitutiv aktiven Form der zur Aktivierung des kanonischen 
NF-!B Signalwegs notwendigen zentralen Kinase IKK2 (IKK2ca) in intestinalen 
Epithelzellen von Mäusen zu einer spontanen Entzündung sowohl des Dick- als auch 
des Dünndarms führte. Die konstitutive Aktivierung von IKK2/NF-!B im Darmepithel 
resultierte in einer Rekrutierung und Aktivierung von Immunzellen und Fibroblasten. 
Darüber hinaus erhöhte die Expression von IKK2ca im Darmepithel die Sensitivität 
gegenüber DSS-induzierter Colitis und steigerte die Tumorrate in chemisch- sowie 
Apc-Mutation-initiiertem Darmkrebs. Intestinale Epithelzellen, die konstitutiv aktive 
IKK2 exprimierten, zeigten eine erhöhte Proliferationsrate, eine Stabilisierung von "-
catenin und eine verstärkte Transkription von Stammzell-assoziierten Faktoren. 
Hierbei ist zu betonen, dass die Expression von IKK2ca im Darmepithel von Mäusen 
zur spontanen Entwicklung von Colon- und Dünndarmtumoren führte. Die in dieser 
Dissertation vorgelegten Daten implizieren, dass die konstitutive Aktivierung von 
IKK2/NF-!B im Darmepithel ausreichend ist um sowohl durch zellinterne Faktoren, 
als auch durch die Erzeugung eines Tumor-förderlichen, entzündlichen Milieus, eine 
Tumorgenese nicht nur zu unterstützten, sondern auch zu induzieren. 
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Abstract 
The NF-!B pathway has been proposed to provide a link between inflammation and 
carcinogenesis. NF-!B signalling is activated by various stress-associated stimuli 
such as pathogen associated molecular patterns (PAMPs), inflammatory cytokines 
and UV-light. Since NF-!B activation induces the expression of anti-apoptotic 
molecules, proinflammatory mediators and anti-microbial peptides, it is a central 
regulator of inflammatory processes. Moreover, various cancers exhibit increased 
activation of NF-!B, not only in tumour infiltrating immune cells, but also in cancer 
cells themselves. In tumour cells NF-!B is believed to act mainly to prevent tumour 
cell death and promote proliferation, whereas in immune cells NF-!B functions to 
induce secretion of cytokines and growth factors to sustain tumour growth and 
angiogenesis. However, so far it has not been addressed whether activation of NF-
!B signalling is sufficient to initiate tumour development through cell-intrinsic tumour-
promoting effects in pre-malignant cells. Here we show that expression of 
constitutively active IKK2, the central kinase inducing canonical NF-!B activation, 
specifically in intestinal epithelial cells of mice results in spontaneous inflammation of 
the colon and the small intestine. Constitutive activation of IKK2/NF-!B in the 
intestinal epithelium induced recruitment and activation of inflammatory cells and 
stromal fibroblasts. Furthermore, expression of IKK2ca in the intestinal epithelium 
rendered mice more susceptible to DSS-mediated colitis and strongly enhanced 
tumour development in chemically induced and Apc-mutation mediated 
tumourigenesis. IKK2ca-expressing IECs exhibited increased proliferative activity, 
stabilisation of "-catenin and elevated expression levels of stem cell associated 
factors. Importantly, expression of IKK2ca in intestinal epithelial cells was sufficient 
for spontaneous tumour development, both in the colon and the small intestine of 
aged mice.  
Therefore results presented in this thesis imply that constitutive activation of 
IKK2/NF-!B in the intestinal epithelium is sufficient to promote and induce intestinal 
tumourigenesis through cell-intrinsic mechanisms, as well as through creating a 
tumour-promoting, inflammatory microenvironment.  
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Abbreviations 
 
ABC   Avidin-Biotin-Complex 
AOM   Azoxymethane 
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Ascl2   Achaete scute like 2 
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CRC   Colorectal Cancer 
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DLK1   Drosophila homolog delta like 1 
DMEM  Dulbecco´s Modified Eagle Medium 
DNA   Desoxyribonucleic acid 
dNTPs  desoxyribonucleotides 
DSS   Dextrane Sulfate Sodium 
DTT   Dithiothreithol 
ECL   Enhanced Chemiluminescence 
EDTA   Ethylene Diamine Tetraacetate 
eGFP   enhanced GFP 
EMSA   Electrophoretic Mobility Shift Assay 
FCS   Fetal Calf Serum 
GFP   Green Fluorescent Protein 
GI   Gastrointestinal Tract 
H&E   Hematoxylin and Eosin 
het   heterozygous 
hom   homozygous 
HRP   Horseradish peroxidase 
IBD   Inflammatory Bowel Disease 
IEC   Intestinal Epithelial Cell 
IF   immunofluorescent 
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IHC   immunohistochemistry 
I.p.   intraperitoneal 
i!B#   Inhibitor of NF-!B alpha 
IKK2   Inhibitor of !B Kinase 2 
IKK2ca  Inhibitor of !B Kinase 2 constitutively active 
IL   Interleukin 
IRES   Internal Ribosomal Entry Site 
IVC   Individual Ventilated Cages 
l   liter 
Lgr5   Leucine rich G-protein coupled receptor 5 
LoxP   Locus of X-over P1 
MEFs   Murine Embryonic Fiboblasts 
MEICS  Mean Endoscopic Index of Colitis Severity 
ml   milliliter 
$l   microliter 
MMP   Matrix Metalloprotease 
mRNA  messenger RNA 
NEMO  Nuclear Factor-kappa B essential modulator 
NF-!B   Nuclear Factor-kappa B 
NGS   Normal Goat Serum 
NP-40   Nonident P40 
Olfm4   Olfactomedin 4 
PCR   Polymerase chain reaction 
PBS   Phosphate-buffered saline 
PFA   Paraformaldehyde 
RNA   Ribonucleic Acid 
ROS   Reactive Oxygen Species 
rpm   rounds per minute 
RT-PCR  Real-Time PCR 
SDS   Sodium Dodecyl Sulfate 
SI   Small Intestine 
sFL   loxP flanked Stop cassette 
#-SMA  alpha Smooth Muscle Actin 
TA   Transit Amplifying 
TBE   Tris Boric acid EDTA buffer 
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TNFR1  TNF Receptor 1 (p55) 
TnfRsF19  TNF Receptor superfamily member 19 
UC   Ulcerative colitis 
v/v   volume per volume 
vil   villin 
WT   wild-type 
w/v   weight per volume 
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1. Introduction 
 
1.1 NF-!B signalling 
The Rel/NF-!B family of transcription factors in mammals consists of five members: 
RelA or p65, RelB, c-Rel, p50 (NF-!B1) and p52 (NF-!B2) (Hayden and Ghosh, 
2008). NF-!B molecules consist of a Rel-homology domain (RHD) situated at the N-
terminus that is essential for formation of homo- and heterodimers and is required for 
DNA binding (Hayden and Ghosh, 2008). Nuclear NF-!B dimers bind to specific DNA 
consensus sites in the promoter regions of NF-!B target genes. p65, RelB and c-Rel 
posses a transcription activation domain (TAD) located in the C-terminal part of the 
protein and therefore homo- and heterodimers containing one of these family 
members can mediate transcriptional activation of NF-!B target genes (Hayden and 
Ghosh, 2008). In contrast, homodimers of p50 or p52 or dimers composed of a p50 
and a p52 subunit are not able to activate transcription of NF-!B target genes and 
have instead been suggested to suppress target gene expression. 
 
In unstimulated cells NF-!B target gene expression is prevented by proteins of the 
inhibitor of NF-!B (I!B) family consisting of I!B#, I!B" and I!B%, BCL3, and I!B& or 
I!BNS, as well as p100 and p105, which are precursor forms of p52 and p50, 
respectively (Hayden and Ghosh, 2008). Ankyrin repeats of I!Bs mediate binding to 
NF-!B molecules, which masks the nuclear localisation signals (NLS) of NF-!B. This 
way, the I!Bs prevent nuclear accumulation of NF-!B. In addition, I!B# contains a 
nuclear export signal (NES) that exports I!B-NF-!B complexes back into the 
cytoplasm (Hayden and Ghosh, 2008).  
 
For NF-!B activation, I!Bs have to be degraded to release NF-!B dimers and allow 
their nuclear accumulation. The activation of NF-!B is under control of the so-called 
IKK-complex, which is composed of two kinases, I!B kinase 1 (IKK1 or IKK#) and I!B 
kinase 2 (IKK2 or IKK") and the regulatory subunit NF-!B essential modulator 
(NEMO or IKK') (Hayden and Ghosh, 2008). The latter is devoid of kinase activity, 
but nevertheless is essential for the activation of the IKK-complex. IKKs 
phosphorylate I!B# on two particular serine residues, Ser32 and Ser36. This 
phosphorylation pattern generates a phospho-degron signal that marks I!B# for K48-
linked polyubiquitination by the "TrCP-SCF complex and is followed by its 
proteasomal degradation (Hayden and Ghosh, 2008). Free NF-!B dimers are then 
    Introduction 
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able to translocate to the nucleus, where they can induce transcription of NF-!B 
target genes.  
Two distinct pathways for the activation of NF-!B have been described. The classical 
or canonical NF-!B pathway is triggered by inflammatory cytokines such as TNF and 
IL-1, by bacterial and viral products through Toll-like receptors (TLRs) and 
intracellular nucleotide-binding and oligomerization domain (NOD) like receptors 
(NLRs), by irradiation, reactive oxygen species (ROS) and other stress factors. The 
canonical pathway leads to nuclear translocation of NF-!B dimers mainly consisting 
of p65, p50 and c-Rel and subsequent activation of genes coding for proinflammatory 
cytokines and chemokines, adhesion molecules and anti-apoptotic proteins. The non-
canonical or alternative NF-!B pathway induces the processing of p100 to p52 
(Hayden and Ghosh, 2008). Alternative NF-!B signalling is mainly induced upon 
ligation of receptors belonging to the TNF receptor superfamily, such as the receptor 
for BAFF (B-cell activating factor belonging to the TNF family, Tnfsf13b) or 
lymphotoxin-! receptor (Vallabhapurapu and Karin, 2009). Induction of the alternative 
pathway also results in transcriptional upregulation of cytokines and chemokines but 
additionally controls the organisation of lymphoid tissues and the development and 
survival of lymphoid cells. Processing of p100 is induced by phosphorylation of two 
particular serine residues, Ser866 and Ser870, in the C-terminal part of the molecule. 
This processing of p100 requires NIK-mediated activation of IKK1 and occurs 
independently of IKK2 or NEMO (Hayden and Ghosh, 2008). 
 
The generation of mice lacking specific subunits of the IKK-complex allowed 
investigation of the distinct functions of each individual IKK subunit (Pasparakis et al., 
2006; Xiao et al., 2001). Studies with cells lacking NEMO showed that NEMO is 
indispensable for canonical NF-!B signalling and in the absence of this subunit no 
canonical NF-!B activation takes place. Similar experiments revealed that IKK2 is 
mainly responsible for activating NF-!B in the canonical pathway, though deletion of 
IKK2 does not completely block NF-!B activation. Residual NF-!B activity is 
mediated by IKK1, since the deletion of both kinases leads to complete blockade of 
NF-!B function, as it is the case in the absence of NEMO. IKK1 was shown to 
mediate phosphorylation of p100 at two particular serine residues in the C-terminal 
part of the protein, leading to its partial proteolysis, which gives rise to p52 (Xiao et 
al., 2001). Thus, while canonical NF-!B activation mainly depends on IKK2, non-
canonical NF-!B activation depends solely on IKK1.  
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Depending on the NF-!B activating signal, different pathways are triggered and 
different upstream molecules are in charge for activating the IKK complex. IKK 
activation downstream of TNF stimulation will be described in further detail as an 
example of a signal transduction pathway leading to NF-!B activation. Upon ligation 
of TNF to TNFR1 the latter induces intracellular signalling cascades triggering 
programmed cell death (apoptosis) on the one hand but also the induction of the NF-
!B pathway and the mitogen activated protein kinase (MAPK) pathways leading to 
activation of JNK, p38 and ERK on the other hand. 
 
 
 
Figure 1   Activation of the NF-!B signalling cascade downstream of TNFR1 
Upon ligation of TNF to TNFR1 adapter molecules are recruited to the cytoplasmic part of the 
receptor. Various ubiquitination and phosphorylation events result in activation of NF-!B and MAPK 
signalling and the subsequent upregulation of pro-inflammatory and anti-apoptotic molecules. In the 
absence of NF-!B and MAPK activation, TNF signalling results in apoptosis. For details see text. 
 
Upon binding of TNF to TNFR1, a number of proteins required for the activation of 
the TNF-induced signalling cascade are recruited to the plasma membrane. Through 
its cytoplasmic protein-protein interaction domain named death domain (DD), the 
central adapter TNFR1-associated death domain (TRADD) protein is bound to the 
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receptor. Furthermore receptor interacting protein 1 (RIP1) kinase, TNF receptor 
associated factors TRAF2 and TRAF5, which are both endowed with ubiquitin ligase 
activity, as well as the cellular inhibitors of apoptosis cIAP1 and cIAP2 become part 
of this receptor-proximal signalling complex (Varfolomeev and Vucic, 2008; Vlantis 
and Pasparakis, 2010). Through the generation of knockout cells for these 
components of the TNF-signalling cascade it has been shown that TRADD, RIP1 and 
TRAF2/5 are important for robust activation of NF-!B downstream of TNFR1 (Ea et 
al., 2006; Ermolaeva et al., 2008; Tada et al., 2001). 
 
Ligation of TNFR1 by TNF results in polyubiquitination of RIP1, establishing a 
platform for the recruitment and activation of kinase molecules required for the 
induction of NF-!B and MAPK pathways. Analysis of knockout cells has revealed that 
polyubiquitination of RIP1 depends on the ubiquitin ligases TRAF2 and TRAF5 (Tada 
et al., 2001). Furthermore cIAP1 and cIAP2 were shown to be important for signalling 
through TNFR1 (Varfolomeev et al., 2008). K63-linked polyubiquitination of RIP1 has 
turned out to be of major importance for the activation of TNF-induced signalling and 
the downstream activation of NF-!B and MAPK signalling (Adhikari et al., 2007; Ea et 
al., 2006). It has been suggested that these K63-linked polyubiquitin chains on RIP1 
form a docking site for the so called TAK1 signalling complex composed of 
Transforming growth factor-"-activated kinase1 (TAK1) and the TAK binding proteins 
TAB1 and TAB2 (Ea et al., 2006). TAB1 and TAB2 are considered to be responsible 
for binding to ubiquitin chains of RIP1. Furthermore recruitment of the IKK-complex is 
also mediated by ubiquitinated RIP1 (Ea et al., 2006). TAK1 has been proposed to 
be responsible for phosphorylation and therefore activation of IKKs and upstream 
kinases of the MAPK pathway (Wang et al., 2001).  
 
Though the described signalling model had found wide acceptance, a recent study 
showed that the lack of RIP1 did not prevent activation of NF-!B downstream of 
TNFR1, suggesting that RIP1 is not required for the activation of NF-!B (Wong et al., 
2010). This raises the possibility that either the role of RIP1 is cell type specific or 
that other molecules can compensate for the loss of RIP1 and activate the 
downstream pathway. 
    Introduction 
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1.2 The gastrointestinal tract and anatomy of the intestinal epithelium 
The intestinal tract consists of the small intestine, composed of (from cranial to 
caudal) the duodenum, jejunum and ileum and is followed by the further distally 
located large intestine or colon. The main function of the small intestine is digestion 
of food and absorption of nutrients. In the colon, in addition to the nutrient absorption, 
water is reabsorbed from the faeces. Furthermore the intestine harbours a large 
number of immune cells and therefore represents a major part of the immune 
system.  
 
 
Figure 2   Gastrointestinal tract of mice 
Schematic representation of the gastrointestinal tract of mice. Figure adapted from NIAID.com 
 
A cross section through the intestine reveals the following structures from the outside 
to the inside. The outer part of the intestine is formed by two muscle layers, the inner 
circular muscle and the outer longitudinal muscle layer, which together are 
responsible for peristalsis, regulated tissue contractions that propagate the intestinal 
contents further distally. The muscle layers are followed by the submucosa, which 
harbours big blood and lymphatic vessels as well as nerves embedded in an irregular 
connective tissue. The innermost layer, the mucosa, can be separated into three 
parts: the intestinal epithelium that lines the intestinal lumen, the lamina propria 
harbours the immune cells of the digestive tract in a loose connective tissue and the 
muscularis mucosa, a thin smooth muscle layer that separates the mucosa from the 
submucosa. 
    Introduction 
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The intestinal epithelium forms a single cell layered barrier that separates cells in the 
lamina propria from luminal contents. This barrier prevents the contact of mucosal 
immune cells by commensal bacteria and various antigens residing in the lumen. 
Disturbance of epithelial integrity leads to an encounter of immune cells with immune 
reactive components of the intestinal lumen, resulting in an inflammatory response 
that impairs intestinal immune homoeostasis. Indeed, patients suffering from 
inflammatory bowel disease (IBD) such as Ulcerative Colitis (UC) or Crohn’s Disease 
(CD) display a disturbance in the intestinal epithelial barrier function (McGuckin et al., 
2009; Roda et al., 2010). Therefore, maintaining intestinal epithelial integrity is 
essential for the health of an individual. 
 
Although the intestinal tract is lined by a single cell-layered epithelium composed of 
intestinal epithelial cells (IECs), the epithelium of the small intestine and the colon 
each display a characteristic architecture and are composed of various kinds of 
specialised epithelial cells. The mucosa of the small intestine is organised into 
protrusions that project into the lumen, the villi, and mucosal invaginations called the 
crypts of Lieberkühn (see Fig. 3) (Reya and Clevers, 2005). The presence of villi 
enlarges the surface area where absorption of nutrients takes place. Crypts harbour 
the proliferating epithelial compartment that consists of stem cells and the transit 
amplifying (TA) cells that fuel the villi with new IECs. In contrast to the small intestine, 
the surface of the colonic mucosa is flat and does not possess villi (Fig. 3) (Reya and 
Clevers, 2005). However, also the colonic epithelium is organised in crypts with the 
stem cell compartment at the crypt bottom and the adjacent TA region. The intestinal 
epithelium is one of the most actively regenerating tissues of the mammalian body, in 
which the whole epithelium is renewed every 3 to 5 days (Brittan and Wright, 2004; 
Radtke and Clevers, 2005). New IECs derive from stem cells at the crypt bottom that 
divide only once per day and give rise to new stem cells and TA cells. The TA cells 
undergo cell divisions more frequently (every 12-16 hours) and are responsible for 
replenishment of the epithelium (Marshman et al., 2002). TA cells remain in the crypt 
for about two days and divide four to five times before they undergo cell cycle arrest 
and migrate towards the apical part of the crypt (van der Flier and Clevers, 2009). 
During this migratory phase epithelial precursors start differentiating into one of the 
four intestinal epithelial cell types, namely the absorptive enterocytes and three 
secretory cell types: goblet cells, enteroendocrine cells and in the small intestine also 
Paneth cells (van der Flier and Clevers, 2009). Enterocytes or columnar epithelial 
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cells are the most abundant cell type in the epithelium and make up more than 80% 
of all IECs (van der Flier and Clevers, 2009). Enterocytes possess a brush border at 
the apical side and are responsible for the uptake of nutrients. Goblet cells are the 
most frequent cell type of the secretory lineage. Goblet cells secrete mucins and 
trefoil factors and thus produce the protective mucus layer that prevents tissue 
damage from luminal contents and hinders bacteria to get into direct contact with 
IECs (McGuckin et al., 2009; van der Flier and Clevers, 2009). Enteroendocrine (or 
neuroendocrine) cells can be found throughout the intestinal tract and these cells 
coordinate intestinal functions by secreting peptide hormones such as gastrin, 
secretin, serotonin and substance P, which regulate secretion of digestive juices and 
contraction of intestinal muscles. 
 
Figure 3   Tissue architecture of the small intestine and colon.  
a. The surface area of the small intestinal mucosa is increased due to formation of protrusions, called 
villi. A single cell-layered epithelium separates the mucosa from the intestinal lumen. Stem cells and 
proliferating precursors (TA cells) of intestinal epithelial cells (IECs) are located in epithelial 
invaginations, the crypts of Lieberkühn. Paneth cells are located at the crypt bases in between stem 
cells (stem cells depicted in blue and red).  
b. The mucosal surface of the colon is flat, though crypts are arranged in the same way as in the small 
intestine and harbour stem cells and TA cells but are devoid of Paneth cells. 
Figure adapted from Reya and Clevers, 2005  
 
Paneth cells reside at the base of small intestinal crypts and with a life expectancy of 
more than three weeks they are the most long-lived cells of the epithelium after stem 
cells (Bjerknes and Cheng, 1981). Paneth cells play an important role in the 
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regulation of the bacterial outgrowth in the intestinal tract by producing antimicrobial 
peptides such as lysozyme and defensins (Wehkamp and Stange, 2006).  
 
In contrast to Paneth cells, which upon differentiation migrate towards the crypt base, 
differentiating IECs move towards the apical part of the mucosa (Reya and Clevers, 
2005). When terminally differentiated IECs have reached the tip of small intestinal villi 
or the apical part of the colonic mucosa, they are shed off into the lumen. This is 
regulated through a specific form of cell death, termed anoikis, which is initiated by 
detachment from the basal membrane (Gilmore, 2005). 
 
Although it was known that the stem cells of the intestinal epithelium are located at 
the lower part of the crypts in both the colon and the small intestine, the exact 
position and identity of this cell type remained elusive for a long time due to the lack 
of specific markers reliably labelling epithelial stem cells. However, recent reports 
have provided evidence that intestinal crypts harbour two types of stem cells with 
different kinetics in cell division and different localisation (Li and Clevers, 2010). Stem 
cells at the base of the crypt, also known as crypt-base columnar cells, are actively 
cycling with a dividing frequency of about once per day (Barker et al., 2007). These 
cells produce Ki67 and express Lgr5 and Ascl2, two molecules proposed to label this 
stem cell compartment (Barker et al., 2007; van der Flier et al., 2009). The second 
population of stem cells is located further towards the lumen of crypts at the +4 
position (4th cell from the crypt bottom) and is negative for Lgr5 or Ascl2 (Barker et 
al., 2007; van der Flier et al., 2009). These cells are cycling very rarely, they do not 
produce Ki67 and they are referred to as quiescent stem cells. Quiescent stem cells 
have been identified to exist also in other tissues, such as the hair follicle and the 
bone marrow (Li and Clevers, 2010). This quiescent stem cell compartment is 
thought to function as a backup system that only replicates under stress conditions, 
such as extensive epithelial damage upon irradiation, and under these circumstances 
gives rise to new actively cycling crypt base columnar cells (Li and Clevers, 2010; 
Scoville et al., 2008). Although some molecules have been proposed, thus far no 
marker has been identified that exclusively labels the quiescent stem cell 
compartment. For instance, Bmi-1 is a chromatin associated factor expressed in +4 
stem cells in the small intestine (Li and Clevers, 2010), but also Lgr5 positive base 
columnar cells were shown to express this protein (van der Flier et al., 2009). 
Currently it is not clear, whether Lgr5 positive and Bmi-1-expressing cells represent 
fully overlapping cell populations. Importantly, the base columnar and quiescent stem 
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cell compartments were reported to function independently of each other. Indeed, 
deletion of Bmi-1 did not affect Ascl2 positive stem cells at the crypt base (van der 
Flier et al., 2009). 
 
1.3 Wnt signalling pathway 
It is well established that Wnt signalling is crucial for proper development and 
maintenance of the intestinal epithelium (Fevr et al., 2007; Korinek et al., 1998). The 
Wnt pathway is responsible for differentiation and proliferation of the intestinal 
epithelium, as well as for proper positioning of the different intestinal epithelial cell 
types along the crypt-villus axis through regulating the expression of the 
EphB/ephrin-B system (Batlle et al., 2002). In addition, the Wnt pathway is essential 
for maintaining intestinal epithelial stem cells, since deletion of Tcf4 leads to 
depletion of the stem cell compartment and early postnatal death in mice (Korinek et 
al., 1998). Induced deletion of "-catenin in the intestinal epithelium of adult mice 
disrupted intestinal homoeostasis and resulted in loss of intestinal functions due to 
loss of proliferating cells and stem cells (Fevr et al., 2007). 
 
Along the basal-apical axis of the intestinal epithelium, Wnt signalling is highest at 
the stem cell containing crypt base and gradually decreases towards the luminal part 
of the mucosa. This is not only reflected in a declining expression of Wnt target 
genes, but also in a decrease of the ratio of cytoplasmic versus nuclear "-catenin 
abundance when IECs move towards the apical part of the crypt. These observations 
clearly show that the main driving force behind proliferation of IECs and maintenance 
of stem cells is the Wnt signalling pathway. This signalling cascade shows a high 
degree of conservation throughout the animal kingdom underscoring the importance 
of this pathway in developmental processes (Klaus and Birchmeier, 2008). 
 
Activation of the transcription factor "-catenin is the central outcome of the Wnt 
signalling pathway (see Fig. 4). If not membrane-bound to adherens junctions via its 
association with E-cadherin, cytoplasmic "-catenin is targeted for proteasomal 
degradation at the so-called “destruction complex”. The destruction complex is 
composed of the scaffolding proteins adenomatous polyposis coli (APC) and 
Axin2/Conductin, which bind "-catenin and expose particular N-terminal serine and 
threonine residues of "-catenin for phosphorylation. Through phosphorylation of 
these target sites by casein kinase l (CK1) and glycogen synthase kinase 3" 
(Gsk3"), "-catenin is targeted to the "-TrCP-SCF complex, which in turn is 
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responsible for polyubiquitination and proteasomal degradation of the molecule 
(Clevers, 2006). When a Wnt-ligand binds to the cognate receptor complex, 
composed of a Frizzled (Frz)-receptor and the low-density lipoprotein receptor-
related protein 5/6 (LRP5/6) co-receptor, the destruction complex is reorganized due 
to relocalisation of Dishevelled (a protein acting upstream of "-catenin and GSK3") 
and Axin to the phosphorylated receptor complex at the cell membrane. Therefore, "-
catenin is not phosphorylated at its N-terminus and thus accumulates in the 
cytoplasm and translocates to the nucleus, where it binds to transcription factors of 
the T cell factor/lymphocyte enhancer factor (TCF/LEF) family (Clevers, 2006). These 
dimers can induce transcription of Wnt target genes, which encode proteins involved 
in proliferation such as c-myc and Cyclin D1, but also proteins involved in tissue 
remodelling (matrix metalloprotease 7, MMP7) or cell positioning (EphB receptors), 
as well as proteins produced in stem cells (Lgr5/Gpr49, Ascl2, Sox9) (Batlle et al., 
2002; Brabletz et al., 1999; Crawford et al., 1999; He et al., 1998; Shtutman et al., 
1999; Tetsu and McCormick, 1999; van der Flier et al., 2009). 
.  
Figure 4   Wnt-signalling pathway 
The Wnt-pathway is activated upon ligation of a Wnt-ligand to the cognate Frizzled-receptor complex. 
This leads to recruitment of dishevelled and Axin2 to the receptor complex and thus to inactivation of 
the so-called destruction complex, comprising the tumour suppressor Apc, as well as Axin2 and the 
kinases CK1 and GSK3". When Wnt is present "-catenin can accumulate, translocate to the nucleus 
and activate TCF/LEF transcription factors and thereby induce expression of Wnt target genes. In the 
absence of Wnt signal cytoplasmic "-catenin is marked for ubiquitin-mediated degradation through 
phosphorylation by CK1 and GSK3" and thereby its accumulation and the transcription of target 
genes are prevented. Figure adapted from Reya and Clevers, 2005  
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Because of the obvious role for "-catenin activation in the differentiation and 
proliferation of IECs, it is clear that deregulation of this pathway might have 
deleterious consequences for intestinal homoeostasis. Indeed, both in humans and in 
mice mutations associated with intestinal carcinogenesis often affect components of 
the Wnt signalling cascade, leading to an enhancement of cytoplasmic and nuclear 
accumulation of "-catenin and thus uncontrolled production of Wnt target genes. 
Mutations leading to activation of the Wnt pathway often affect APC, resulting in the 
formation of a non-functional APC molecule that cannot exert its functions and 
ensure degradation of cytoplasmic "-catenin (Fodde et al., 2001). Mutations in Apc 
are very common in both hereditary cancer syndromes like familial adenomatous 
polyposis coli (FAP), in which over 95% of FAP patients were shown to carry Apc 
mutations and in spontaneous intestinal cancers, with more than 80% of 
spontaneous colon cancers harbouring mutant forms of Apc (Laken et al., 1999). The 
function of APC as a true tumour suppressor protein was proven in mice lacking APC 
in IECs or carrying a mutated Apc allele, as such mice spontaneously develop 
intestinal tumours (see further). These observations indicate that deregulation of the 
Wnt pathway might be an early event in intestinal tumour formation and underscore 
the need for controlling Wnt signalling for the maintenance of intestinal homoeostasis 
and to prevent tumour development (Bjerknes and Cheng, 1981; Fodde et al., 2001). 
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1.4 Murine models of colitis and intestinal cancer 
Various colitis models have been established in mice that mimic human IBD. Apart 
from genetic disease models such as IL-10 knockout mice or TNF(ARE animals that 
develop spontaneous intestinal disease, chemically inducible inflammatory models 
have been established (Kontoyiannis et al., 1999; Kuhn et al., 1993; Rennick et al., 
1995). For instance, supplying mice with dextran sulfate sodium (DSS) in the drinking 
water results in inflammation of the distal colon that is similar to disease 
characteristics in UC patients (Cooper et al., 1993; Okayasu et al., 1990). So far the 
exact mechanisms through which DSS induces colonic inflammation are not 
completely understood. DSS acts as an irritant on the colonic epithelium, resulting in 
mucosal ulceration and translocation of luminal contents into the mucosa, triggering 
an inflammatory response. Disease severity induced by DSS ingestion has been 
shown to depend on the bacterial microflora. Mice held under germ-free conditions 
show enhanced sensitivity to DSS colitis, implying that bacteria exert a protective role 
in this epithelial erosion based colitis model (Kitajima et al., 2001).  
 
DSS can be administered following an intraperitoneal injection with the pro-
carcinogen Azoxymethane (AOM) in order to induce colonic tumour formation. AOM 
is hydroxylated in the liver by cytochromes P450 to an intermediate compound 
(methylazoxymethanol, MAM) and then transported in bile to the intestine. Factors 
derived from commensal bacteria are required for the generation of the alkylating 
methyldiazonium that induces DNA mutations through alkylation of Guanine residues 
at the O6 position (Greten et al., 2004; Neufert et al., 2007). Therefore, AOM induces 
DNA damage specifically in the intestinal epithelium of the colon (Neufert et al., 2007; 
Tanaka et al., 2003). In order to accelerate proliferation of cells with AOM-induced 
mutations, multiple cycles of DSS are administered to the mice interrupted by a 
regeneration phase, in which mice receive normal drinking water. In this way, DSS 
invokes a chronic colitis associated with damage to the mucosal epithelium and 
regenerative proliferation of intestinal epithelial cells (Suzuki et al., 2006). 
 
To study AOM-induced tumour formation that does not depend on inflammation-
mediated tumour promotion, AOM is repetitively applied in weekly doses without the 
following DSS administration and tumour formation is assessed usually 30 weeks 
after the first AOM injection (Neufert et al., 2007). 
 
In addition to chemically induced cancer models, also genetic mouse models for 
intestinal carcinogenesis have been established. For instance, mouse models 
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carrying mutations that occur in human colorectal cancer patients such as mutations 
in the Apc tumour suppressor gene were generated.  
 
In this respect, Apcmin mice carry a point mutation in codon 850 in the Apc gene that 
leads to production of a truncated Apc polypeptide (Moser et al., 1990; Su et al., 
1992). Apcmin mice develop multiple small intestinal polyps mimicking intestinal 
polyposis in FAP patients. Apcmin animals exhibit a very aggressive phenotype with 
100-200 polyps growing in their small intestines and therefore exhibit a reduced life 
expectancy (Moser et al., 1990). A different Apc mutation in Apc1638N mice results 
in a milder disease manifestation (Fodde et al., 1994). In these mice a truncated 
version of the molecule, comprising the amino-terminal 1638 amino acids of Apc is 
produced, which is achieved through interruption of the coding sequence by a NEO-
cassette (Fodde et al., 1994). Apc1638N mice only develop four to six small intestinal 
polyps in the very proximal part of the small intestine (duodenum and jejunum) at an 
age of about five to nine months (Fodde et al., 1994). When mice are left to age for 
one year, they were reported to show lesions also in the colon and the stomach 
(Fodde et al., 1994). In all mouse APC-models lesions occur only upon loss of 
heterozygocity for the wild-type Apc allele in tumour initiating epithelial cells.  
 
In the AOM/DSS tumour protocol mutations affecting "-catenin that render the 
molecule resistant to degradation are very frequent (Takahashi et al., 2000; 
Takahashi and Wakabayashi, 2004). Therefore mutations leading to activation of Wnt 
signalling are involved in different intestinal tumour models, indicating that 
perturbations of the Wnt pathway are an early event in intestinal tumourigenesis. 
 
1.5 NF-!B in intestinal disease 
A number of recent studies have demonstrated the importance of functional NF-!B 
signalling in the intestinal epithelium for maintaining tissue homoeostasis. Deletion of 
NEMO specifically in intestinal epithelial cells (NEMOIEC-KO) triggers spontaneous 
development of chronic colitis in mice (Nenci et al., 2007). NEMOIEC-KO mice display 
scattered apoptotic events in the epithelium already at young age, which may result 
in a disturbance of the intestinal epithelial barrier leading to colonic inflammation. 
This hypothesis is supported by the observed translocation of commensal bacteria 
into the colonic mucosa, associated with recruitment of immune cells that secrete 
various cytokines and chemokines. Mice lacking either TAK1 or p65 specifically in 
IECs confirmed the essential role for NF-!B activation in the intestinal epithelium as 
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demonstrated by NEMOIEC-KO mice. TAK1IEC-KO mice exhibited severe intestinal 
disease affecting the colon and the small intestine and resulted in death within the 
first day after birth (Kajino-Sakamoto et al., 2008). Already during embryogenesis (at 
embryonic day 18), though the intestinal morphology still appeared normal,     
TAK1IEC-KO mice displayed increased apoptosis of IECs and transcription levels of 
inflammatory mediators were elevated. Since deletion of TAK1 blocks activation of 
NF-!B and MAPK signalling, it is not surprising that TAK1IEC-KO mice display a more 
severe phenotype than NEMOIEC-KO mice. While NEMOIEC-KO mice only lack 
canonical NF-!B activity and can induce production of anti-apoptotic and pro-
inflammatory molecules through activation of MAPK signalling, TAK1IEC-KO mice 
cannot. 
 
Furthermore, 10-15% of mice lacking the NF-!B subunit p65 specifically in the 
intestinal epithelium developed intestinal bleeding few days after birth and died 
shortly after weaning age (Steinbrecher et al., 2008). However, 85-90% of p65IEC-KO 
mice remained disease free throughout adulthood and did not display histological 
abnormalities in the intestinal tract. This milder phenotype of p65IEC-KO mice 
compared to NEMOIEC-KO animals most probably can be explained by the remaining 
activity of other NF-!B transcription factors in IECs. Indeed, whereas deletion of 
NEMO completely blocks activation of canonical NF-!B signalling, loss of p65 in the 
intestinal epithelium only partially impairs NF-!B dependent gene transcription. 
However, when challenged with DSS, p65IEC-KO animals exhibited more severe colitis 
development than control littermates (Steinbrecher et al., 2008). This observation 
underscores the importance of NF-!B signalling in IECs for maintaining intestinal 
homoeostasis under stress conditions.  
 
In accordance with the idea that partial inhibition of NF-!B signalling does not result 
in impaired intestinal homoeostasis under basal conditions, mice lacking IKK2 in 
IECs (IKK2IEC-KO mice) did not exhibit a spontaneous phenotype (Greten et al., 2004). 
Only IKK2IEC-KO mice with an additional deletion of IKK1 in IECs (IKK2, IKK1IEC-KO) 
developed a colonic disease similar to NEMOIEC-KO animals (Nenci et al., 2007), 
indicating that under basal conditions residual NF-!B activation in IECs mediated by 
IKK1 is sufficient to maintain intestinal homoeostasis. However, IKK2IEC-KO mice were 
more sensitive to high doses of DSS-administration, arguing that full NF-!B signalling 
capacity in IECs is necessary to respond appropriately during DSS-triggered colitis 
(Greten et al., 2004).  
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Together, these above described studies show that NF-!B signalling in IECs is 
essential for maintaining epithelial integrity under steady state levels, during which 
low levels of NF-!B activity appear to suffice for IEC maintenance. However, to 
control colitis severity in chemically induced colitis high levels of epithelial NF-!B 
activation are necessary. 
 
Apart from studying the role of NF-!B activation during intestinal inflammation, mice 
carrying conditional alleles of IKK2 have also been used to investigate the role of NF-
!B activation in intestinal tumourigenesis. In the AOM/DSS-induced model of colon 
cancer, IKK2IEC-KO mice exhibited reduced colorectal carcinogenesis. Since the lack 
of IKK2 in the intestinal epithelium led to increased IEC apoptosis upon DSS 
treatment, the authors suggested that cells carrying AOM-induced carcinogenic 
mutations were eliminated and therefore could not give rise to tumours (Greten et al., 
2004). Thus, epithelial IKK2 activity was suggested to contribute to AOM/DSS-
induced cancer development through its anti-apoptotic effect in early initiated tumour 
cells. In contrast to IKK2IEC-KO mice, mice lacking IKK2 in myeloid cells (IKK2myeloid-KO) 
did not reveal a differential tumour incidence but instead harboured significantly 
smaller colonic tumours than control animals. This indicates that IKK2 in myeloid 
cells promotes tumour growth rather then tumour initiation (Greten et al., 2004). Lack 
of IKK2 in myeloid cells reduced the production of cytokines and chemokines during 
AOM/DSS treatment. Since cytokines and chemokines are thought to act as growth 
factors for tumour cells (Coussens and Werb, 2002), this observation suggests that 
shortage of these inflammatory factors in IKK2myeloid-KO mice impairs tumour growth 
(Greten et al., 2004). 
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1.6 Cre/LoxP conditional gene targeting 
Conditional gene targeting by Cre/LoxP mediated recombination allows cell type 
specific analysis of gene function in mice. In addition, the Cre/LoxP technique 
permits to investigate the function of genes that are essential for mouse development 
and of which the corresponding conventional full body knockout mouse does not 
reach adulthood (Rajewsky et al., 1996; Sauer and Henderson, 1988). To generate a 
cell type specific knockout of a particular allele, this allele is flanked by specific 34 bp 
sequences, the so-called LoxP-sites, in the same orientation. Alleles with these 
LoxP-flanked sequences are referred to as ‘floxed’ alleles. Mice carrying these floxed 
alleles are then crossed to mice expressing a bacteriophage P1-derived Cre 
recombinase transgene under the control of a cell type specific promoter. This Cre 
recombinase binds to and mediates recombination between the LoxP sites, resulting 
in excision of the DNA flanked by the LoxP sites specifically in the cell type producing 
Cre.  
 
The Cre-LoxP system can also be used in order to induce the expression of a 
transgene only in a specific cell type. This is achieved when the coding sequence of 
this transgene is preceded by a stop-signal that is flanked by LoxP-sites, thereby 
preventing its expression. Cre-mediated recombination between the LoxP-sequences 
removes the Stop-signal and allows expression of the transgene specifically in the 
cell type in which Cre is present. 
 
1.7 Project description 
Genetic mouse models, in which NF-!B signalling was impaired specifically in the 
intestinal epithelium, have shown that activation of NF-!B in intestinal epithelial cells 
protects the intestine during inflammatory processes (Greten et al., 2004; Nenci et 
al., 2007; Steinbrecher et al., 2008; Vallabhapurapu and Karin, 2009). A complete 
blockade of canonical NF-!B activity in intestinal epithelial cells resulted in severe 
chronic colitis, demonstrating that basal levels of functional NF-!B signalling are 
required to preserve intestinal immune homoeostasis (Nenci et al., 2007). Partial 
inhibition of NF-!B signalling by deletion of either IKK2 or p65 in IECs rendered mice 
more sensitive to DSS-induced colitis (Greten et al., 2004; Steinbrecher et al., 2008), 
indicating that NF-!B activity in IECs is essential to cope with inflammation 
associated tissue damage. Indeed, IKK2-deficient IECs displayed increased 
apoptosis upon DSS treatment, suggesting a cytoprotective effect of NF-!B activation 
in IECs under inflammatory conditions. On the other hand, the anti-apoptotic effect of 
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NF-!B activation in IECs promotes intestinal tumour development, as lack of IKK2 in 
intestinal epithelial cells reduced tumour incidence in AOM/DSS-induced cancer 
experiments due to enhanced cell death of carcinogen exposed IECs (Greten et al., 
2004). These loss-of-function approaches in mice indicate that though NF-!B 
activation in IECs preserves intestinal homoeostasis and therefore is protective 
during excessive intestinal inflammation, at the same time it acts as a tumour 
promoter in intestinal tumourigenesis. 
 
Considering these findings we decided to use a gain-of-function approach to 
investigate in vivo the outcome of increased NF-!B activity in intestinal epithelial 
cells. Therefore, we applied Cre/LoxP mediated recombination to generate mice that 
express a constitutively active IKK2 molecule selectively in intestinal epithelial cells. 
With this mouse model we wanted to address the role of constitutive IKK2/NF-!B 
activation specifically in the intestinal epithelium in mucosal homoeostasis, 
inflammatory disease and intestinal tumourigenesis. 
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2. Material and Methods 
 
2.1  Material 
 
2.1.1 Chemicals 
Chemicals and compounds were purchased from Sigma & Aldrich, AppliChem, 
Merck, Roth, MP, VWR, Bayer, Ratiopharm, Dako, Vector Laboratories, GE 
Healthcare, Thermo Scientific, Li-Cor Biosciences 
 
2.1.2 Material for mouse work 
High resolution mini-endoscope, Coloview with Xenon light source, Karl-Storz 
(Tuttlingen, Germany) 
Ketamin 10 mg/ml, Ratiopharm 
Rompun 2%, Bayer Healthcare 
Azoxymethane (AOM), Sigma 
Dextran Sulfate Sodium (DSS), MW 36000-50000, MP 
Haemoccult sensa, Beckmann Coulter 
Syringes, Braun and Injection Needles, Terumo and Braun 
 
2.1.3 Material for Histology 
Tissue retriever 2100, PickCell 
Tissue processor, Leica TP1020 
Rotary Microtome, Leica RM2255 
Modular tissue embedding center, Leica EG1150 and Leica EG1150 C 
Fluorescent microscope, Leica DM5500 
ABC Kit Vectastain Elite (Vector, PK 6100)  
Avidin/Biotin Blocking Kit (Vector, no. SP-2001) 
Liquid DAB Substrate Chromogen System (DakoCytomation, Code K3466) 
Fluoromount-G, SouthernBiotech 
Glas slides, Menzel 
 
2.1.4  Material for Biochemistry 
Homogenizer Precellys 24, PeqLab 
2 ml tubes for homogenisation, Peqlab  
1,4 mm Zirconium oxide beads for tissue homogenisation, Peqlab  
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Gel casting system and SDS-Page system, Biorad 
Powersupply, Biorad 
Protease Inhibitor Cocktail complete mini EDTA free, Roche 
PhosphoStop, phosphatase inhibitor, Roche  
Bradford reagent, Biorad 
Protein Marker PeqGold Protein Marker V, PeqLab 
PVDF membranes Immobilon-P, Millipore 
Films Hyperfilm ECL, Amersham 
Odyssey detection system 
 
2.1.5 Molecular Biology Reagents and Equipment 
Trizol reagent, Invitrogen 
RNA extraction RNeasy mini kit, Qiagen 
RNase-free DNase set, Qiagen 
SuperScriptlll cDNA synthesis Kit, Invitrogen  
RT Cycler ABI HT 7900 Cycler, Applied Biosystems  
Power SYBR® Green PCR Master Mix, Applied Biosystems  
TaqMan® Gene Expression Master Mix, Applied Biosystems 
MicroAmp® Optical Adhesive Film, Applied Biosystems 
MicroAmpTM Optical 384-Well Reaction Plate, Applied Biosystems 
 
2.1.6 Laboratory equipment 
Centrifuges, Eppendorf and Haereus 
Thermomixer, Eppendorf  
PCR-cyclers, Biorad DNA Engine, Biometra and Eppendorf 
DNA ladder, Peqlab 
Primers, Invitrogen and Metabion 
Bio Photometer, Eppendorf 
NanoDrop ND8100, PeqLab 
QIAfilter plasmid purification kit, Qiagen 
 
2.1.7 Cell culture 
DMEM (Gibco) 
TrypLETM Express (Gibco) 
100x Penicillin (10000 U/ml)/Streptomycin (10000 $g/ml) (Gibco) 
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100x L-Glutamine (200 mM) (Gibco) 
100x Sodiumpyruvate (100 mM) (Gibco) 
Fetal Calf Serum (PAN) 
PBS (without Ca2+ and Mg2+) (Gibco) 
Lipofectamine Reagent 2000 (Invitrogen) 
Plastic ware for cell culture from BD Falcon, Millipore, TPP, Corning Tubes 
Eppendorf 1,5 ml and 2 ml reaction tubes 
8 x 0,2 ml tube stripes Biozym 
 
2.1.8 Software 
Photoshop CS3, Leica microscopy Software Leica application suite, Prism Graph,  
Microsoft Office, OpenOffice Sun Microsystems, EndnoteX2 
 
2.1.2  Buffers and Solutions 
 
2.1.2.1 Washing buffers 
 
PBS (1x) pH 7,3 
NaCl   137 mM 
KCl      2,7 mM 
Na2HPO4 – 7H2O    4,3 mM 
KH2PO4     1,4 mM 
 
TBS (1x) pH 7,5 
Tris-Base  24,2 g 
NaCl   80 g 
 
2.1.2.2 Buffers and solutions for immunostainings 
 
Endogenous peroxidase blocking buffer (for IHC) 
NaCitrate    0,04 M  
Na2HPO4   0,121 M  
NaN3    0,03M  
H2O2    3 % (v/v)  
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TEX Protease K buffer pH 8.0 (for protease mediated antigen retrieval) 
Tris-base  50 mM  
EDTA     1 mM 
Triton X-100  0,5% (v/v) 
 
2.1.2.3 Preparation of protein extracts 
 
High salt RIPA lysis buffer (for preparation of total cell extracts) 
HEPES (pH 7,6)    20 mM  
NaCl    350 mM  
MgCl2        1 mM 
EDTA         0,5 mM 
EGTA         0,1 mM 
Glycerol     20% (v/v) 
1% Nonident P-40, Protease inhibitor and Phosphatase inhibitors were added prior to 
use. 
 
Cytoplasmic and nuclear protein extraction buffers 
Buffer A (hypotonic lysis buffer) 
HEPES (pH 7.6)    10 mM  
KCl      10 mM  
MgCl2        2 mM    
EDTA        0.1 mM  
After the swelling step 0,8% (v/v) Nonident P-40 was added. 
Protease inhibitor and Phosphatase inhibitors were added prior to use 
 
Buffer C (high salt nuclear lysis buffer) 
HEPES (pH 7.8)    50 mM  
KCl      50 mM  
NaCl    300 mM  
EDTA        0.1 mM  
Glycerol      10 % (v/v) 
Protease inhibitor and Phosphatase inhibitors were added prior to use 
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2.1.2.4 Buffers and solutions used for Western Blot analysis 
 
Tris-glycine electrophoresis buffer 
Tris-Base    25 mM 
Glycine  250 mM 
SDS      0,1% (w/v) 
 
SDS-polyacrylamid gel 
10% resolving gel (for 20 ml) 
H2O    7,9 ml 
30% acrylamide mix 6,7 ml 
1,5 M Tris (pH 8,8)  5,0 ml 
10% (w/v) SDS   0,2 ml 
10% (w/v) APS   0,2 ml 
TEMED    0,012 ml 
 
5% stacking gel (for 10 ml) 
H2O    6,8 ml 
30% acrylamide mix 1,7 ml 
1 M Tris (pH 6,8)  1,25 ml 
10% (w/v) SDS   0,1 ml 
10% (w/v) APS   0,1 ml 
TEMED    0,01 ml 
 
Transfer Buffer (for semidry transfer) 
Tris-Base    25 mM 
Glycine  192 mM 
Methanol    20% (v/v)  pH 8,3-8,5 
 
Blocking buffer 
PBS + 0,1% (v/v) Tween-20 + 5% (w/v) nonfat dry milk 
 
primary antibody dilution buffer 
TBS + 0,1% (v/v) Tween-20 + 5% (w/v) BSA or 5% (w/v) nonfat dry milk 
  Material and Methods 
 33 
5x Laemmli loading buffer 
Tris-HCl (pH 6,8)  250 mM 
SDS      10% (w/v) 
Glycerol     50% (v/v) 
Bromphenolblue      0,01% (w/v) 
"-Mercaptoethanol    10% (v/v) (can be added prior to use) 
 
Home made ECL solution 
Stock solutions 
Tris-HCl (pH 8,5)  100 mM 
Luminol   250 mM (in DMSO) 
Paracoumaric acid (PCA)   90 mM (in DMSO) 
H2O2      30% (v/v) 
 
Solution 1 
10 ml of 10 mM Tris-HCl (pH 8,5) with 2,5 mM Luminol (100 $l of stock) and 400 $M 
PCA (44 $l of stock). 
 
Solution 2 
10 ml of 10 mM Tris-HCl (pH 8,5) with 7 $l 30% (v/v) H2O2 (5,4 mM). 
The two solutions were mixed and applied on the membrane. 
 
2.1.2.5 Buffers and solutions used for EMSA 
 
1x TBE 
Tris-base   89 mM 
Boric acid   89 mM 
EDTA      2 mM 
 
Nondenaturing gels (for 25 ml) 
H2O      19,25 ml 
10x TBE       1,25 ml 
30% Acrylamide/Bisacrylamide mix    4,14 ml 
10% (w/v) APS       315 $l 
TEMED         40 $l 
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10x EMSA binding buffer 
Tris-HCl (pH 7,5)  100 mM 
NaCl    500 mM 
DTT      10 mM 
 
2.1.2.6 Buffers used for DNA extraction and genotyping PCRs 
 
Tail lysis Buffer 
Tris-HCl (pH 8,5)  100 mM 
EDTA        5 mM 
NaCl    200 mM 
SDS      0,2 % (w/v) 
0,1 mg Proteinase K (10mg/ml in 50 mM Tris, pH 8.0) per 500 $l lysis buffer was 
added prior to use. 
 
TE buffer 
Tris-HCl (pH 8)  10 mM 
EDTA (pH 8)     1 mM 
 
10x TAG buffer 
Tris-base (pH 8,5)  200 mM 
KCl    500 mM 
 
TAE Buffer (25x) for 10 l 
Tris-Base  1210 g 
EDTA (pH 8.0) 500 ml of 0,5 M solution 
Acteic acid  285.5 ml 
 
DNA loading buffer 
15 % (w/v) Ficoll 400 was resolved in distilled water at ~50 °C. Orange G was added 
till the colour turned red 
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2.2 Methods 
 
2.2.1  Animal handling and mouse experiments 
 
2.2.1.1 Mouse maintenance 
Mice were housed in individually ventilated cages (IVC) in a specific pathogen free 
(SPF) mouse facility and in a conventional animal facility in the Institute for Genetics 
at the University of Cologne. Mice had permanent access to regular chow diet 
(Teklad Global Rodent 2018, Harlan) and acidified water. Animals were kept at a 
regular 12 hours light and 12 hours dark cycle. 
 
For breeding male and female mice were set together at a minimum age of 6 weeks. 
Litters were weaned at 3 weeks of age and marked with an eartag. Tail biopsies were 
taken at the same time for isolation of genomic DNA and genotyping  
 
Care of all mice was within institutional animal care committee guidelines. All animal 
procedures were conducted in accordance with European, national and institutional 
guidelines and protocols and were approved by local government authorities 
(Bezirksregierung Köln, Cologne, NRW, Germany). 
 
2.2.1.2 Generation of conditional mice 
To generate mice that express constitutively active IKK2 specifically in the intestinal 
epithelium R26IKK2casFL (Sasaki et al., 2006) mice were bred with villin Cre 
transgenics (Madison et al., 2002) (R26IKK2ca sFL; villin Cre mice). To generate 
double mutant mice Apc1638N (Fodde et al., 1994) were crossed to R26IKK2ca sFL; 
villin Cre mice. All mice were maintained in a C57BL/6 background. 
For all experiments littermates only carrying loxP-flanked alleles served as control 
mice. 
 
2.2.1.3 Endoscopy 
Mice were anaesthetized by intraperitoneal injection of 200 $l per 20 g bodyweight a 
Ketamine/Rampun mixture. The distal colon was analysed with a high-resolution 
mouse mini-endoscope, denoted Coloview, from Karl Storz. For imaging of the distal 
colon area the endoscope was gently inserted into the anus. Constant airflow 
induced dilation of the intestine and allowed an unperturbed view on the colonic 
mucosa. Disease index determined via endoscopy was composed of 5 scoring 
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features indicative for intestinal disease severity, each of which was scored ranging 
from 0 to 3 with 0 being healthy and 3 indicating severe inflammation, as has been 
described before (Becker et al., 2005). The sum of the following parameter scores 
results in murine endoscopic index of colitis severity (MEICS), an index between 0 
and 15, allowing the evaluation of disease severity. The characteristics scored during 
examination were stool consistency, vascularisation pattern, fibrin abundance, 
thickening of the bowel wall and surface appearance of the mucosa. Furthermore the 
existence of tumours, ulcers and other intestinal lesions could be assessed through 
endoscopic examination. 
After endoscopy mice were allowed to recover from anaesthesia or were immediately 
killed. 
 
2.2.1.4 Dextran sulfate sodium (DSS)-induced colitis 
In order to induce colonic inflammation resembling UC in human IBD patients, a well-
established protocol of Dextran sulfate sodium (DSS) feeding was conducted 
(Cooper et al., 1993; Okayasu et al., 1990). Mice were fed DSS ad libidum in the 
drinking water. DSS (1,5% w/v or 2% w/v) was dissolved in millipore water and 
autoclaved prior administration. During the course of DSS experiments mice were 
monitored on a daily basis to assess bodyweight, stool consistency and intestinal 
bleeding. In order to monitor intestinal inflammation and damage of the colonic 
mucosa, stool samples of each animal were collected every day. Fresh stool pellets 
were spread on Heamoccult test sheets (Beckmann Coulter) in order to visualize 
occult blood. Blood scores from 0 to 4 were determined as follows: no blood in stool: 
score 0, occult blood visualized with Haemoccult kit: score 1, blood in stool visible in 
stool when spread: score 2, stool pellet covered by blood: score 3, gross bleeding 
from anus: score 4. Stool consistency scores from 0 to 4 were determined by the 
following scoring criteria: regularly formed stool pellets: score 0, still formed but softer 
stool pellets: score 1, enlarged, soft stool pellets: score 2, spread unformed stool: 
score 3, heavy diarrhoea with stool spread around the anus: score 4. The sum of 
blood score and stool consistency scores results in the total stool score. 
 
2.2.1.5 AOM/DSS-induced colorectal cancer protocol 
To induce colorectal colitis associated cancer (CAC), mice were undertaken an 
established chemically induced inflammation dependent cancer protocol (Neufert et 
al., 2007; Tanaka et al., 2003). On day zero of the treatment mice received an 
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intraperitoneal injection with 10 mg/kg bodyweight Azoxymethane (AOM) diluted in 
sterile PBS. In order to induce acute intestinal inflammation, on the same day, 
drinking water was replaced by water supplemented with DSS. During the first 2 
weeks of the experiment mice were weighed daily and stool was analysed for 
diarrhoea and occult blood as described for DSS treatment. During the course of the 
treatment and at the end of the experiment mice were endoscopised in order to 
monitor disease and tumour development in vivo. Mice were sacrificed 9 weeks after 
the AOM injection and tissue samples were processed for histological evaluation. 
 
2.2.1.6 AOM-induced tumour protocol 
To induce colorectal cancer independently of inflammation driven tumour promotion, 
mice were repetitively injected with AOM without additional DSS feeding (Neufert et 
al., 2007). Mice received 10 mg/kg bodyweight AOM diluted in sterile PBS i.p. once 
per week for 5 consecutive weeks. Mice were monitored regularly to monitor health 
status. 
 
2.2.1.7 Sacrifice of mice 
Mice were euthanized by cervical dislocation.  
 
2.2.1.8 Tissue processing 
After cervical dislocation the abdominal cavity was opened by a longitudinal incision. 
The large and small intestines were removed by cutting out the colon in close 
proximity to the anus and the small intestine was cut after the pylorus. The intestines 
were placed into PBS and cleaned from mesentery and fat. The intestinal contents 
were carefully squeezed out with scissors and pieces of the gastrointestinal tract 
were taken for histological examination and RNA extraction. 
 
For examination of bigger parts of intestinal tissue the “swiss-roll technique” was 
applied. For this the whole colon was opened longitudinally and the contents were 
removed. The tissue was then placed with the mucosa facing down on a dish. With 
the help of injection needles the tissue was rolled up lengthwise to form a so-called 
“swiss-roll” with the muscle tissue facing to the inside of the roll and the mucosa 
outwards. Small intestine of adult mice was cut into three pieces and individual rolls 
were prepared from these segments. About 3 to 5 mm long pieces of intestinal tissue 
were used for preparation of cross sections. 
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2.2.2 Histology 
 
2.2.2.1 Preparation of intestinal tissue for histological evaluation 
For histological examination tissue was fixed in histology cassettes over night at 4°C 
in 4% (w/v) phosphate buffered paraformaldehyde. The samples were passed 
through an increasing concentrations of ethanol for tissue dehydration (for 2 h each 
in 30% (v/v), 50% (v/v), 70% (v/v), 96% (v/v) and 2x in 100% (v/v) ethanol), were 
kept for two times 2 h each in xylol and then transferred to paraffin in order to be 
embedded in paraffin blocks. Intestinal tissue was sectioned with a microtome at 3 to 
4 $m thickness and stained with haematoxylin and eosin for histological evaluation. 
 
2.2.2.2 Haematoxylin and Eosin staining of intestinal tissue sections 
To de-wax tissue sections, glass slides were placed in xylol for 20 min, then put for 2 
min in each of the following ethanol-solutions for tissue rehydration: 100% (v/v) 
ethanol (or 100% (v/v) isopropanol), 95% (v/v) ethanol, 75% (v/v) ethanol and then in 
PBS for 5 min. Slides were washed in tap water for 1 min and placed into Meyers' 
Haematoxylin for 2 min. After being kept in tepid tap water for maximally 20 s the 
slides were incubated in tap water for another 15 min at room temperature to blue, 
followed by a short incubation in deionised water. Samples were placed in Eosin 
staining solution for 1 min and the excessive staining removed by washing the slides 
for 6 to 7 times in tap water. Samples were placed for 2 min in each 75% (v/v), 96% 
(v/v) and 100% (v/v) ethanol to dehydrate and were subsequently cleared in xylol. 
Coverslips were mounted with Entellan. 
 
2.2.2.3 Immunostainings 
For immunofluorescent and immunohistochemical (IHC) staining, slides were de-
waxed in xylol and transferred through an ascending series of ethanol solutions as 
described under H&E staining procedure. After washing twice for 5 min in tap water 
for IHC endogenous peroxidase activity was blocked for 15 min at room temperature 
in endogenous peroxidase blocking buffer. Thereafter slides were washed three 
times for 5 min in tap water and antigen unmasking in form of heat induced epitope 
retrieval was performed, either in a pressure steam cooking device, where samples 
were heated for 20 min to 120°C or over night at 80°C in citrate buffer, pH 6 
supplemented with 0,05% (v/v) Tween-20. Alternatively (for cytoplasmic and nuclear 
visualisation of !-catenin) retrieval was performed in TE pH 9 (10 mM Tris, 1 mM 
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EDTA). Antigen unmasking by Proteinase K digestion was performed for F4/80 
immunostainings. In this case, tissue was covered with 20 $g/ml Proteinase K in TEX 
buffer for 20 min at room temperature. After washing the slides in PBS unspecific 
background was blocked in PBS with 10% (v/v) normal goat serum, 0,3% (v/v) Triton-
X-100 and Avidin (Avidin was only added in case of IHC). Primary antibodies were 
incubated on slides over nigh at 4°C diluted in PBS, 0,2 % (v/v) cold fish skin gelatine 
and Biotin in case of IHC and in PBS supplemented with 0,2 % (v/v) cold fish skin 
gelatine in case of IF. After washing three times in PBS with 0,05% (v/v) Tween-20 
the secondary antibody diluted in PBS with 10% (v/v) normal goat serum was applied 
for one hour at room temperature, followed by three 5 min washes in PBS with 0,05% 
(v/v) Tween-20. For IF nuclei were counterstained with DAPI and cover slides 
mounted with Fluoromount. In case of IHC after the secondary antibody an Avidin-
Biotin-HRP complex (ABC Kit) was incubated on the samples for 30 min at room 
temperature and after washing staining was developed with DAB chromogen. 
Precipitate formation was followed under a microscope and the reaction stopped 
after sufficient staining intensity was reached by immersing the slides in PBS. To 
ensure equal staining conditions all samples were incubated with DAB staining 
solution for the same time. Nuclei were counterstained in Meyers' Haematoxylin for   
1 min, when immunostainings for nuclear antigens were performed, and for 2 min in 
case of cytoplasmic and cell surface epitopes. Tissue was mounted with Kaisers' 
gelatine after a short wash in PBS or dehydrated in descending series of ethanol 
solutions, cleared in Xylol and mounted with Entellan. 
 
Table 1: Primary antibodies and conditions for immunostainings: 
Antigen Host Company Clone  Dilution Retrieval 
B220 rat home made RA3 6B2 1:1000 10 mM Citrate, pH 6 
"-catenin mouse BD Clone 14 1:5000 10 mM Tris, 1mM EDTA, pH 9 
CD3 rabbit Abcam Ab 5690 1:200 10 mM Citrate, pH 6 
F4/80 rat home made A3-1 1:100 Protease K digestion 
FLAG rabbit Sigma F7425 1:500 10 mM Citrate, pH 6 
Gr1 rat BD Pharmingen 1A8 1:500 10 mM Citrate, pH 6 
#H2A.X mouse Millipore JBW301 1:1000 10 mM Citrate, pH 6 
Ki67 rat Dako TEC-3 1:1000 10 mM Citrate, pH 6 
$SMA mouse Sigma 1A4 1:2000 10 mM Citrate, pH 6 
Sox9 rabbit Millipore AB5535 1:1000 10 mM Citrate, pH 6 
  Material and Methods 
 40 
Table 2: Secondary antibodies and conditions used for immunostainings 
Antigen Antibody modification Host Company Clone Dilution 
mouse IgG biotinylated goat Biozol BA-9200 1:1000 
rabbit IgG biotinylated goat Perkin Elmer NEF813 1:500 
rat IgG biotinylated rabbit DAKO E0468 1:1000 
rabbit IgG Alexa488 goat Invitrogen A11008 1:1000 
rat IgG Alexa488 goat Invitrogen A11006 1:1000 
 
2.2.3  Biochemical analysis 
 
2.2.3.1 Isolation of intestinal epithelial cells (IECs) from colon and small
  intestine 
After euthanasia the peritoneal cavity was opened, the intestines removed and 
transferred into cold PBS. IECs were isolated according to the published protocol 
(Ukena et al., 2007). The colon and the small intestine were cut open longitudinally 
and the intestinal contents were removed by washing in cold PBS. Colons/small 
intestines were placed into separate 50 ml Falcon tubes with pre-warmed PBS 
supplemented with 1 mM DTT and shaken for 10 min at 180 rpm and 37°C to remove 
mucus and debris. The tissue was shortly washed in PBS, transferred into new tubes 
and incubated in HANK's salt solution (HBSS) supplemented with 1,5 mM EDTA for 
15 min at 37°C and 180 rpm. For efficient detachment of epithelial cells and crypts, 
tubes were vortexed vigorously at full speed for about 1 minute. Colon/SI tissue was 
removed with forceps and IECs were pelleted by centrifugation for 10 min at        
1200 rpm. Pellets of colon and SI IECs were resuspended in 1 ml and 3 ml PBS 
respectively and transferred into eppendorf tubes. After another centrifugation for      
5 min at 5000 rpm pellets were either shock frozen in liquid Nitrogen, or processed 
for protein extraction or RNA preparation. 
 
2.2.3.2 Preparation of IEC protein extracts 
For total extracts of colonic or small intestinal IECs, cells were lysed in an 
appropriate amount of high salt RIPA lysis buffer (depending on the size of IEC 
pellets, lysis buffer volumes ranging from 50 $l to 800 $l were used) supplemented 
with protease- and phosphatase inhibitors. For lysis the cells were kept on ice for    
30 min and during this incubation period tubes were inverted repetitively. The lysis 
step was followed by 20 min centrifugation at 4°C and full speed to pellet cell debris. 
The supernatant containing cytoplasmic and nuclear proteins was harvested. 
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2.2.3.3 Preparation of cytoplasmic and nuclear protein extracts 
For separation of cytoplasmic and nuclear proteins, IEC pellets were resuspended in 
buffer A and kept on ice for 5 min for hypotonic swelling of cells. Addition of NP-40 to 
a final concentration of 0,8% (v/v) and incubation for 10 min on ice allowed cell lysis 
without opening the nuclei. Nuclei were separated from the cytoplasmic protein 
fraction by centrifugation at full speed for 1 min at 4°C. Supernatant containing the 
cytoplasmic protein fraction was transferred to a fresh tube and frozen away. The 
procedure was repeated in order to lyse cells that were not lysed during the first lysis 
step. To remove remaining cytoplasmic extracts nuclei were washed twice in buffer A 
without NP-40. Afterwards the whitish nuclear pellet was resuspended in an 
appropriate amount of high salt buffer C. Nuclear lysis was performed on ice for      
20 min and the extracts were isolated by a centrifugation step at full speed and 4°C 
for 10 min. The supernatant containing the nuclear protein fraction was transferred 
into a fresh tube and frozen away. 
 
2.2.3.4 Assessment of protein concentration by Bradford assay 
To determine the protein concentration, samples were diluted 1:10 in lysis buffer and 
2 $l were added to 1 ml of Bradford solution. To generate a protein concentration 
standard curve 0,5 $g, 1 $g, 2 $g, 5 $g and 10 $g BSA each were diluted in 1 ml of 
Bradford solution and incubated at RT for 10 min. Protein concentrations were 
measured with a spectrophotometer at an absorbance of 595 nm. For calculation of 
protein concentrations the BSA-standard curve was applied. 
 
2.2.3.5 Western Blot analysis 
To reduce disulfide bonds and denature proteins prior to loading, samples were 
boiled in 1x Laemmli loading buffer for 10 min. 
 
Equal amounts of protein as determined by Bradford analysis were separated 
according to size by electrophoresis on 10% SDS-polyacrylamid gels (SDS-PAGE). 
Gels were run under denaturing conditions in Tris-Glycine electrophoresis buffer until 
sufficient separation of protein bands at the molecular weight of interest was 
reached.  
Proteins were transferred to PVDF membranes via semidry electrotransfer. First 
PVDF membranes were activated by incubation in 100% (v/v) methanol for 2 to 3 
minutes and were then placed in transfer buffer. Prior to transfer SDS gels were 
equilibrated and 3 mm thick Whatman paper was soaked in semi dry transfer buffer. 
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From bottom to top the following assembly was built up to allow transfer of proteins 
from SDS gels to the membranes. A piece of Whatman paper was covered by the 
PVDF nitrocellulose membrane, followed by the gel and another sheet of Whatman 
paper. Per cm2 membrane 1 mA current was applied for 90 to 120 minutes to assure 
efficient transfer of proteins. After protein blotting, membranes were washed in PBS 
and, to reduce unspecific binding of antibodies, membranes were blocked in PBS 
with 0,1 % (v/v) Tween-20 and 5% (w/v) non-fat dry milk under agitation. Primary 
antibodies were applied either over night at 4°C or for 1 to 3 hours at room 
temperature and were diluted either in PBS with 0,1 % (v/v) Tween-20 and 5% (w/v) 
milk or TBS with 0,1% Tween-20 and 5% (w/v) BSA. Excessive antibodies were 
removed by washing in PBS with 0,1 % Tween-20. Membranes were incubated with 
HRP-conjugated secondary antibodies raised against mouse, rabbit or goat 
immunoglobulins were diluted in PBS with 0,1 % (v/v) Tween-20 and 5% (w/v) non 
fat dry milk for 1 h at room temperature under agitation. 
 
After washing in PBS with 0,1 % (v/v) Tween-20 and depending on signal intensity, 
protein bands were visualized either with homemade ECL solution, commercial ECL, 
ECL plus or with ECL Femto. For signal development membranes were soaked with 
the corresponding ECL solution for at least 1 min. Chemiluminescent films were 
placed on the membranes in cassettes and were exposed for various time points. 
Exposed films were first developed in AGFA developer solution and fixed in AGFA 
Fixer solution.  
 
Loading differences of proteins were identified by comparison of the "-actin or #-
tubilin levels. 
 
Table 3: Primary antibodies used for WB analysis 
Antigen Host Company Clone Dilution 
"-actin goat polyclonal Santa Cruz I19 1:1000 
Ascl2 rabbit polyclonal abcam ab74499 1:1000 
Active "-catenin mouse monoclonal Millipore 8E7 1:1000 
"-catenin mouse monoclonal BD 14 1:2000 
I!B$ rabbit polyclonal Santa Cruz C-21 1:1000 
IKK2 rabbbit monoclonal Cell Signaling 2C8 1:1000 
Lamin A/C goat polyclonal Santa Cruz N-18 1:1000 
$-tubulin mouse monoclonal Sigma B-5-1-2 1:5000 
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Table 4:Secondary antibodies used for WB analysis 
Antigen Host Company Clone Dilution 
mouse IgG sheep Amesham Pharmacia NA9310V 1:3000 
rabbit IgG donkey Amesham Pharmacia NA934V 1:5000 
goat IgG donkey Jackson ImmunoResearch 705-035-033 1:3000 
 
2.2.4. Molecular Biology 
 
2.2.4.1 Electrophoretic mobility shift assay (EMSA) 
In order to determine DNA-binding activity of nuclear NF-!B, we performed NF-!B-
DNA binding assays with nuclear protein extracts prepared form IECs. 
To allow binding of NF-!B transcription factors to a consensus NF-!B site in a DNA 
probe, the following reaction was set up and incubated at room temperature in the 
dark for 40 min. 2 $l 10x EMSA binding buffer, 1 $l of poly dIdC (1-2 $g/$l), 1 $l of   
25 mM DTT, 2,5% (v/v) Tween-20, 1 $l of NF-!B probe labelled with IR Dye 781 and 
the corresponding volume of 5 to 10 $g nuclear protein extract. The final volume was 
adjusted to 20 $l with nuclease-free water. After the binding reaction 2 $l of orange 
loading dye were added. 
NF-!B probe sequence 
5’AGT TGA GGG GAC TTT CCC AGG C 3’ 
5’G CCT GGG AAA GTC CCC TCA ACT 3’ 
Both oligonucleotides were labelled with IR Dye 781 at the 5’ end. 
During the binding reaction of the probes the nondenaturing gel was pre-run in 0,5x 
TBE buffer at 9 V per cm of gel. EMSA was run at 9 V per cm of gel protected from 
light. The result was visualized with Odyssey detection system. 
 
2.2.4.2 Extraction of RNA 
For extraction of RNA from IECs or whole colon tissue, samples were homogenised 
in 1 ml of Trizol reagent (Invitrogen). Samples were left for 20 min at room 
temperature to allow complete lysis of nuclei. Centrifugation for 10 min at full speed 
pelleted cell debris and membranes. The supernatant was transferred into a new 
eppendorf cup and incubated at room temperature for another 5 min. 200 $l 
chloroform per 1 ml of Trizol were added to the homogenate and the tubes shaken 
vigorously by hand for about 15 s to extract nucleic acids, followed by a 5 min 
incubation step at room temperature. To separate the organic and aqueous phases, 
samples were centrifuged for 15 min at full speed. The clear upper aqueous phase 
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was transferred into a fresh tube, an equal volume of 70% (v/v) ethanol was added 
and the solution was mixed gently by pipetting. Up to 700 $l of this mix were loaded 
on a Qiagen RNAeasy column. Columns were centrifuged for 1 min at 9000 g and 
the process repeated with the remaining extracts. The column filter was thereafter 
washed with washing buffer (provided by the manufacturer), which was removed by 
centrifugation (15 s at 9000 g). To perform on column genomic DNA digestion, the 
column was equilibrated with equilibration buffer (provided by the manufacturer), the 
buffer removed by centrifugation and then the DNA digestion performed for 15 to     
20 min at room temperature with RNase-free DNase in RDD buffer (provided by the 
manufacturer). Digestion of genomic DNA was followed by two washing steps and 
filter bound RNA was then eluted in nuclease free water. Until further use RNA was 
stored at -80°C. 
1 $l of RNA solution was run on an agarose gel to asses RNA quality. Furthermore a 
PCR for "-actin was performed with RNA to check for contamination with genomic 
DNA. 
Concentration and purity of RNA were assessed by photometric analysis. 
 
2.2.4.3 cDNA synthesis 
1 $g RNA was used for in vitro cDNA synthesis with Superscript lll kit (Invitrogen) 
according to the manufacturers instructions. In a final reaction volume of 10 $l 1 $g of 
RNA was mixed with 1 $l of 10 mM dNTPs and 1 $l random hexamer primers         
(50 ng/$l). This reaction was incubated for 5 min at 65°C to allow annealing of 
primers to RNA. Then 10 $l of the cDNA-Synthesis mix consisting of 2 $l 10x RT-
reaction buffer, 4 $l 25 mM MgCl2, 2 $l of 0,1 M DTT, 1 $l RNase OUT (40 U/$l) and 
1 $l of SuperScript lll polymerase (200U/$l) (all provided by the manufacturer) were 
added to the annealing mix after the latter was incubated on ice for a few minutes. 
For reverse transcription the following reaction was carried out on a PCR Cycler:    
10 min at 25°C, 50 min at 50°C for cDNA synthesis and finally 85°C for 5 min for 
termination of the reaction. RNA was digested by addition of 1 $l of RNase H and 
incubation for 20 min at 37°C. The resulting reaction volume was diluted 10-fold with 
nuclease-free H2O and 2 $l of this cDNA solution were used for quantitative real time 
PCR. 
To assure proper synthesis of cDNA in all samples, 2 $l of cDNA solution were 
subjected to an actin-PCR. 
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2.2.4.4 Quantitative real time PCR 
For quantitative real time PCRs samples were run in duplicates. Probe-based 
Taqman quantitative RT-PCR reactions were performed in a final volume of 12 $l.     
2 $l of cDNA were mixed with 6 $l of 2x Mastermix (Applied Biosystems), 0,6 $l of 
primer-probe mix (Applied Biosystems) and 3,4 $l of water in 384-well plates. All 
Taqman probes were purchased from Applied Biosystems 
The PCR programme applied was suggested by the manufacturer (Applied 
Biosystems) and was composed of an activation step for 10 min at 95 °C, followed by 
40 cycles of 10 s at 95°C and 1 min at 60 °C. 
For Sybr-Green based quantitative RT-PCRs 2 $l of cDNA were added to 1,2 $l of   
20 $M primer mix, 6 $l of 2x reaction buffer (Applied Biosystems) and 2,8 $l of water. 
The PCR programme applied was suggested by the manufacturer: after 10 min at 
95°C, 40 cycles of 95°C for 10 s, annealing at 60°C for 20 s and an elongation step 
of 40 s at 72°C were used. After these 40 cycles the PCR-amplicons were subjected 
to a dissociation stage. 
Primers for Sybr-Green quantitative RT-PCR were purchased from Invitrogen and 
primer sequences were obtained from http://pga.mgh.harvard.edu/primerbank/. 
RNA expression levels were determined according to the comparative ((CT method. 
Therefore, the Ct value (which corresponds to the cycle number when the 
amplification plot crosses the fixed threshold) for each gene and sample was 
substracted from the Ct value of an endogenous control (the reference gene; villin, 
Gapdh or TATA box binding protein) to generate the (CT value. Relative 
quantification was performed by using the ((CT.  
 
Table 5: Taqman probes used for quantitative RT-PCR analysis 
Gene Taqman probe 
Cxcl-1 = KC Mm00433859_m1  
Cxcl-10 = IP-10 Mm00445235_m1 
Cxcl-16 Mm00469712_m1  
Ccl20 Mm00444228_m1 
IL-1b Mm00434228_m1  
IL-6 Mm00446190_m1  
IL-12a, p35 Mm00434165_m1  
IL-23, p19 Mm00518984_m1  
IL-12b, p40 Mm99999067_m1  
IL-17A Mm00439619_m1  
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Table 5 (continued): Taqman probes used for quantitative RT-PCR analysis 
Gene Taqman probe 
TNF Mm00443258_m1 
TGF-b1 Mm03024053_m1  
Tslp Mm00498739_m1 
Ascl2 Mm01268891_g1 
Olfm4 Mm01320260_m1 
Lgr5 Mm00438890_m1 
Prominin-1 = CD133 Mm00477115_m1  
DLK1 Mm00494477_m1 
MMP7 Mm01168420_m1 
Ptgs2 = Cox2 Mm00478374_m1 
  
Gapdh Mm99999915_g1 
Tbp = TATA box binding protein Mm00446973_m1 
 
Table 6: Primer-sequences for Sybr-Green based quantitative RT-PCR 
Gene forward (5'% 3') reverse (5'% 3') 
Tnfrsf19 ATTCTCTTCCTACTCCACCTG CATAGCCGAAGCCACATTC 
Bmi-1 TATAACTGATGATGAGATAATAAGC CTGGAAAGTATTGGGTATGTC 
Cyclin D1 GCGTACCCTGACACCAATCTC CTCCTCTTCGCACTTCTGCTC 
"-catenin ATGGAGCCGGACAGAAAAGC  CTTGCCACTCAGGGAAGGA 
Axin-2/conductin TGACTCTCCTTCCAGATCCCA  TGCCCACACTAGGCTGACA 
Tcf4 = Tcf7L2 GCACACATCGTTCAGAGCC  GGGTGTAGAAGTGCGGACA  
Tcf1 = Tcf7 AGCTTTCTCCACTCTACGAACA  AATCCAGAGAGATCGGGGGTC 
CD44 TCTGCCATCTAGCACTAAGAGC  GTCTGGGTATTGAAAGGTGTAGC 
ITF-2 = SEM2 CAGCACTGCCGACTACAACA CCATAGCCCGGCTGATTCAT  
Id-2 ATGAAAGCCTTCAGTCCGGTG AGCAGACTCATCGGGTCGT 
c-myc ATGCCCCTCAACGTGAACTTC CGCAACATAGGATGGAGAGCA 
IKK1 GTCAGGACCGTGTTCTCAAGG GCTTCTTTGATGTTACTGAGGGC 
IKK2 CTGAAGATCGCCTGTAGCAAA TCCATCTGTAACCAGCTCCAG 
L1CAM AAAGGTGCAAGGGTGACATTC  TCCCCACGTTCCTGTAGGT  
Lamg2 = laminin #2 CAGACACGGGAGATTGCTACT  CCACGTTCCCCAAAGGGAT  
Ccl6 GCTGGCCTCATACAAGAAATGG GCTTAGGCACCTCTGAACTCTC 
Ccl11 GAATCACCAACAACAGATGCAC ATCCTGGACCCACTTCTTCTT 
Ccl20 GCCTCTCGTACATACAGACGC CCAGTTCTGCTTTGGATCAGC 
Ccl25 TTACCAGCACAGGATCAAATGG CGGAAGTAGAATCTCACAGCAC 
Ccl28 GTGTGTGGCTTTTCAAACCTCA TGCATGAACTCACTCTTTCCAG 
Cxcl5 TGCGTTGTGTTTGCTTAACCG AGCTATGACTTCCACCGTAGG 
Reglll# TTCCTGTCCTCCATGATCAAAA CATCCACCTCTGTTGGGTTCA 
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Table 6 (continued): Primer-sequences for Sybr-Green based quantitative RT-PCR 
Gene forward (5'% 3') reverse (5'% 3') 
IL-11 TGTTCTCCTAACCCGATCCCT CAGGAAGCTGCAAAGATCCCA 
   
villin TCAAAGGCTCTCTCAACATCAC AGCAGTCACCATCGAAGAAGC 
Gapdh CATGTTCCAGTATGACTCCACTC GGCCTCACCCCATTTGATGT 
 
2.2.4.5 Preparation of genomic DNA from tail biopsies 
Tail biopsies were placed in 500 $l of tail lysis buffer supplemented with Proteinase K 
(10 mg/ml). Tails were lysed for a minimum of 2 h at 56°C under agitation or over 
night at 56°C with or without agitation to digest the tissue. Undissolved material (hair, 
cartilage and bone) was pelleted by centrifugation for 10 min at full speed. The 
supernatant was transferred into a new tube containing 500 $l isopropanol and the 
tube was inverted several times to precipitate DNA. Genomic DNA was collected at 
the bottom of the tube by 5 min centrifugation at full speed and followed by a washing 
step with 200 $l 70% (v/v) ethanol after discarding the supernatant. After another      
5 min of centrifugation at full speed the pellet was air-dried and then suspended in 
100-200 $l Tris-EDTA buffer. Genomic DNA was used for genotyping PCRs. 
 
2.2.4.6 Genotyping PCRs 
For PCR-based genotyping 2 $l of genomic tail DNA were used per reaction. The 
PCR-reaction mix was composed of 3 $l 10x TAG buffer, 3 $l of 2 mM dNTPs, 3 $l of 
3 $M primer mix, 1,8 $l 25 mM MgCl2, 1,8 $l DNA loading dye, 0,5 $l home made 
Taq-enzyme and 17 $l of H2O in a final volume of 30 $l. Adequate annealing and 
elongation times were used for each typing protocol. To assess PCR results 10 $l 
PCR reaction were run on agarose gels. 
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Table 7:Primer-sequences for genotyping PCRs and PCR-amplified fragment sizes: 
typing for Primer sequences (5'%3') bands 
Apc1638N 
TCAGCCATGCCAACAAAGTCA WT 200 bp  
Tg 400 bp GGAAAAGTTTATAGGTGTCCCTTCT 
R26 knock-in 
AAAGTCGCTCTGAGTTGTTATC 
WT 570 bp  
sFL 450 bp GATATGAAGTACTGGGCTCTT 
GCATCGCCTTCTATCGCCT 
villin Cre 
ACAGGCACTAAGGGAGCCAATG 
WT 900 bp  
Tg 350 bp ATTGCAGGTCAGAAAGAGGTCACAG 
GTTCTTGCGAACCTCATCACTC 
 
Table 8: PCR-programmes for genotyping PCRs 
typing for PCR program cycles 
Apc1638N 
94°C 5 min  
94°C 60 sec 
35 55°C 45 sec 
72°C 45 sec 
72°C 5 min  
 
R26 knock-in 
94°C 3 min  
94°C 30 sec 
35 56°C 30 sec 
72°C 30 sec 
72°C 5 min  
   
villin Cre 
94°C 3 min  
94°C 1 min 
35 67°C 1 min 
72°C 1 min 
72°C 5 min  
 
 
2.2.4.7 Agarose gel electrophoresis 
PCR-amplified DNA fragments were separated according to size by agarose gel 
electrophoresis. Depending on fragment size, 1 to 2 % (w/v) agarose were boiled in 
1x TAE buffer and supplemented with 0,5 mg/ml Ethidiumbromide. Gels were run in 
1x TAE electrophoresis buffer. 
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2.2.5 Cell Biology 
 
2.2.5.1 Culture of human colon cancer cell lines 
HCT116 human colon cancer cells were cultured in DMEM supplemented with     
10% (v/v) FCS, Penicillin/Streptomycin, Pyruvate and Glutamine. Cells were grown to 
confluency in 15 cm Petri dishes and incubated at 37°C and 5% (v/v) CO2. Confluent 
cells were subjected to trypsinisation in order to detach adherent cells from culture 
dishes. Prior to trypsin treatment cells were washed in PBS to remove medium with 
FCS, trypsin solution was applied and the plates were incubated for 5 min at 37°C. 
Trypsin activity was blocked by addition of DMEM with 10% (v/v) FCS. Cells were 
then diluted in fresh medium and were transferred to new plates. 
 
2.2.5.2 Transfection of human colon cancer cells 
The day before transfection cells were detached from the plates by trypsinisation and 
resuspended in growth medium. 1x106 or 3x106 cells were seeded in 10 ml of 
medium on 10 cm Petri dishes. 
Prior to transfection cells were washed in PBS and were starved for 2 h at 37°C in    
9 ml of DMEM medium without FCS and other supplements. Either Polyethylenimine 
(PEI) or Lipofectamin 2000 (Invitrogen) was used as transfection reagent. Per $g of 
plasmid DNA either 4 $l of PEI or 3 $l of Lipofectamin 2000 were added to 1 ml of 
DMEM, mixed and incubated at room temperature for 5 min. In the meantime 
plasmid DNA was placed into tubes. 1 ml of DMEM-transfection reagent mix was 
placed on the plasmid DNA and the tubes were inverted several times. This 
transfection-mix was incubated at room temperature to allow formation of micelles 
with plasmid DNA. After 20 min the transfection mix was added to the cells and 
dishes were shaken horizontally to distribute the mix all over the plate. Cells were 
kept over night in medium with transfection mix, which was replaced by DMEM with 
all supplements. Cells were left another 24 h to grow and were then harvested for the 
preparation of protein extracts. To assure transfection with equal amounts of plasmid 
DNA, empty plasmid was added to complement. 
 
2.2.6  Statistics 
Results are represented as the mean +/- standard deviation (SD).  
Statistical significance between experimental groups was determined by an unpaired 
two-tailed Student's t-test. 
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3. Results 
 
3.1  Constitutive IKK2/NF-!B activation in IECs results in focal inflammation 
of the colon and the small intestine  
To investigate the effect of constitutive IKK2/NF-!B activity in intestinal epithelial cells 
in vivo, a transgenic mouse model was used, in which a FLAG-tagged constitutively 
active IKK2 construct (IKK2ca) together with the coding sequence for enhanced 
green fluorescent protein (eGFP) was introduced into the ubiquitously expressed 
Rosa26 locus (Fig. 5). The constitutively active IKK2ca molecule was generated by 
two serine to glutamate substitutions (S177 and S181) in the activation loop of IKK2, 
thereby mimicking the phosphorylations required for its full enzymatic activity (Sasaki 
et al., 2006). This expression cassette was preceded by a loxP flanked STOP-
cassette, preventing uncontrolled expression of the IKK2ca transgene 
(R26IKK2casFL/sFL). To express IKK2ca specifically in intestinal epithelial cells (IECs), 
R26IKK2casFL/sFL mice were crossed to mice expressing Cre recombinase under the 
control of the intestinal epithelial cell restricted villin promoter (Madison et al., 2002). 
(Fig. 5) The expression of IKK2ca was visualized by immunofluorescent stainings on 
colon cross sections of R26IKK2casFL/sFL; villin Cre transgenic (IKK2caIEChom) mice, 
showing the presence of the FLAG-tagged IKK2ca only in colonic epithelial cells (Fig. 
6a). Expression of IKK2 was highly increased in IKK2caIEChom mice both on mRNA 
expression level as assessed by quantitative real time PCR and in terms of protein 
abundance as shown by Western Blot analysis (Fig. 6b and 6c). Whereas mRNA 
levels of IKK2 were significantly higher in colon IECs of IKK2caIEChom mice, there was 
no difference in the expression levels of IKK1 in the colon of IKK2caIEChom versus 
control mice (Fig. 6b). 
  
Figure 5 
The coding sequence for FLAG-tagged 
constitutively active IKK2 (IKK2ca) followed by the 
DNA sequence for enhanced green fluorescent 
protein (eGFP) were inserted into the ubiquitously 
expressed Rosa26 locus under the control of the 
endogenous R26 promoter. A loxP-flanked stop 
cassette prevents uncontrolled expression of 
IKK2ca molecule. Upon Cre-mediated excision of 
the stop cassette IKK2ca-coding mRNA can be 
transcribed in the tissue of interest and FLAG-
IKK2ca, as well as the eGFP are produced. 
Figure was adapted from Sasaki et al., 2006. 
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Decreased steady state protein levels of I!B#, which upon phosphorylation by IKK2 
is targeted for degradation, indicated an increased activation status of the NF-!B 
pathway in primary small intestinal IECs of IKK2caIEChom mice (Fig. 6c). An 
electrophoretic mobility shift assay (EMSA) with nuclear protein extracts from IECs 
from IKK2caIEChom mice showed increased NF-!B DNA binding activity (Fig. 6d). In 
contrast, no probe shift was observed when nuclear IEC extracts derived from 
IKK2casFL or NEMOIEC-KO mice, the latter ones completely lacking canonical NF-!B 
activity, were analysed. These results show that IECs from IKK2caIEChom mice 
produce high levels of IKK2ca and exhibit increased and persistent activation of NF-
!B in the intestinal epithelium.  
 
Figure 6   Expression of FLAG-IKK2ca in the intestinal epithelium of IKK2ca transgenic mice 
a. Immunofluorescent staining for FLAG shows presence of FLAG-IKK2ca in epithelial cells of the 
colon in IKK2caIEChom and not IKK2casFL mice. 
b. Quantitative RT-PCR analysis revealed higher amounts of IKK2 mRNA in colon IECs from 
IKK2caIEChom mice compared to IKK2casFL controls, whereas IKK1 was not expressed at different 
levels between genotypes. (n = 5)  
c. WB analysis for IKK2 revealed increased levels of IKK2 protein in SI IECs of IKK2caIEChom animals. 
IKK2 was not detectable in IECs isolated from IKK2IEC-KO mice, which lack IKK2 in the intestinal 
epithelium. IECs from IKK2caIEChom mice displayed a decrease in I!B# protein, indicative of IKK2 
activity in IECs. 
d. Increased NF-!B DNA binding as identified by a shift in NF-!B probe migration (marked by an 
arrow) in nuclear extracts from colon and small intestinal IECs of IKK2caIEChom mice versus IKK2casFL 
controls. SI IECs from NEMOIEC-KO mice did not exhibit DNA-binding of NF-!B members. 
Scale bars represent 50 $m 
IKK2caIEChom mice were born at the expected Mendelian ratio and exhibited healthy 
gross appearance. Endoscopic analysis of young adult mice at an age of six to eight 
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weeks did not reveal differences between IKK2casFL control and IKK2caIEChom mice. 
The distal colon of IKK2caIEChom mice showed a normal vascularisation pattern and 
the mucosa was smooth and translucent resulting in a murine endoscopic index of 
colitis severity (MEICS) similar to control mice (Fig. 7a). Endoscopic images of the 
colon did not reveal differences between the two genotypes (Fig. 7b). 
 
Figure 7   Reduced bodyweight and increased length of the small intestine in young  
IKK2caIEChom male mice  
a. Endoscopic analysis of 7 to 9-week-old mice did not show signs of colonic inflammation as depicted 
by similar MEICS (murine endoscopic index for colitis severity) for IKK2casFL (n = 5) and IKK2caIEChom 
(n = 10) animals.  
b. Representative endoscopic colon images from 8-week-old IKK2casFL and IKK2caIEChom mice. 
c. Reduced bodyweight of IKK2caIEChom male mice at 10 weeks of age compared to age- and sex-
matched IKK2casFL controls. (n = 5) 
d. No statistically significant difference in colon length was detectable between genotypes in 10-week-
old male mice. (n = 5) 
e. The same 10-week-old IKK2caIEChom male mice displayed a statistically significant increase in the 
length of the small intestine. (n = 5) 
f. A significantly higher relative length of the small intestine compared to bodyweight of each mouse 
was observed in IKK2caIEChom male mice. (n = 5) 
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However at 10 weeks of age IKK2caIEChom mice showed a mild but statistically 
significant reduction in bodyweight that could point to intestinal disease (Fig. 7c). 
Furthermore, whereas there was no marked difference in the length of the colons, the 
small intestine of the same 10-week-old IKK2caIEChom mice was significantly longer 
than the small intestine of IKK2casFL control mice (Fig. 7d and 7e). The relative length 
of the small intestine compared to the bodyweight of each individual animal was 
therefore significantly higher in IKK2caIEChom than in control mice (Fig. 7f). 
 
On histological sections from the colon and the small intestine of 6-week-old mice 
signs of mild intestinal disease became overt in IKK2caIEChom mice. Whereas the 
distal colon did not show any obvious signs of pathology and only scattered areas 
with a slight increase in crypt length were found, the proximal colon of IKK2caIEChom 
mice displayed mucosal areas with infiltrating cells and inflammation-induced tissue 
alterations were detectable (Fig. 8a). For instance, some crypts located close to 
immune cell infiltrates exhibited alterations in the epithelial structure such as an 
increase in crypt length and densely packed epithelial cells. However, these changes 
appeared in a discontinuous pattern and never affected the whole tissue. In the small 
intestine histological tissue alterations were more obvious (Fig. 8b). Especially in the 
ileum, the distal part of the small intestine, crypts in IKK2caIEChom mice appeared to 
be much longer than in IKK2casFL litter mates, leading to an overall thickening of the 
mucosa and concomitant shortening of villi. Furthermore, these elongated crypts in 
IKK2caIEChom animals were surrounded by inflammatory cells.  
 
Whereas control mice harboured normal numbers of Paneth cells, identified by 
reddish granules on H&E stained sections at the bottom of ileal crypts, the amount of 
Paneth cells was markedly reduced in crypts from IKK2caIEChom mice (Fig. 8b 
compare higher magnifications at the bottom of the figure). Whereas some 
IKK2caIEChom crypts only contained few Paneth cells, some crypts indicated by white 
arrows in Fig. 8b did not have Paneth cells at all. Furthermore the ileum from 
IKK2caIEChom mice harboured elongated crypts with mislocalized Paneth cells, as 
shown in Fig. 8b and marked by a black arrow. 
 
In the proximal small intestine differences between control and IKK2caIEChom animals 
were not as striking, but also in this region of the intestine an elongation of crypts and 
a mild increase in infiltrating cells was observed. Occasionally crypts were found to 
grow on top of each other and the mucosa was thickened. 
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Figure 8   Inflammation in the intestine of young IKK2caIEChom mice 
a. H&E stained histological sections from colons of 6-week-old IKK2caIEChom mice revealed mild crypt 
elongation in the distal part of the colon. In the proximal colon increased amounts of immune cells and 
defined infiltrates surrounding crypts were identified in IKK2caIEChom but not in IKK2casFL mice. 
b. Histological examination of small intestines of IKK2caIEChom mice revealed elongation of crypts 
especially in the ileum (distal small intestine). Ileal crypts of IKK2caIEChom mice frequently lacked 
Paneth cells, which can be identified by eosinophilic granules in crypt bases of wild-type mice (see 
inset with white arrows in IKK2caIEChom mouse). Black arrow in inset marks a mislocalized Paneth cell. 
Note the increase in SI diameter in IKK2caIEChom mice. 
Scale bars represent 50 $m 
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To identify the nature of infiltrating cells in the mucosa of IKK2caIEChom mice 
immunohistochemical (IHC) stainings for Gr1, F4/80, CD3 and B220 were performed 
on colon and small intestinal cross sections from 6-week-old mice in order to 
visualize Gr1 positive granulocytes, macrophages, T-cells and B-cells respectively. 
Whereas control tissue was almost completely devoid of granulocytes, small 
numbers of Gr1 expressing cells were found in the colonic and small intestinal 
mucosa of IKK2caIEChom mice. In the ileum of IKK2caIEChom mice Gr1 positive 
granulocytes were located around the crypts and were also found in between 
epithelial cells (Fig. 9a). 
 
F4/80 positive macrophages were more abundant in the proximal colon from 
IKK2caIEChom when compared to IKK2casFL control mice, indicating that macrophage 
recruitment is increased in colonic mucosa of IKK2caIEChom mice (Fig. 9a). In control 
small intestines macrophages mostly localized to the lamina propria in the villi. In 
contrast, the small intestine of IKK2caIEChom mice showed a shift in F4/80 
macrophage staining to the lamina propria surrounding the crypts, which is the area 
showing the highest inflammatory cell infiltration in this part of the intestine (Fig. 9a). 
IHC for CD3 showed no marked difference in the amount of T-cells between 
IKK2caIEChom and control mice (Fig. 9a). Although areas showing inflammatory 
infiltrates contained higher numbers of CD3-positive T-cells, the overall difference 
was not as pronounced as for granulocytes and macrophages. The same result was 
obtained for B220-positive B-cells, for which only a slight increase in the presence of 
B-cells was observed in intestinal tissue of IKK2caIEChom mice (Fig. 9a). Together, 
these IHC data show that at young age mainly innate immune cells of the myeloid 
lineage contributed to inflammation in IKK2caIEChom mice, whereas cells of the 
adaptive immune system were less frequently involved. 
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Figure 9   Increased recruitment of myeloid cells and elevated expression of inflammatory 
mediators in the intestine of young IKK2caIEChom mice 
a. IHC for Gr1 and F4/80 revealed increased numbers of Gr1-positive granulocytes and F4/80-positive 
macrophages both in the colon and the small intestine of 6-week-old IKK2caIEChom mice. In the ileum 
macrophages accumulated around crypts in IKK2caIEChom mice, whereas in wild-type animals 
macrophages mainly localized to villi. The number of CD3 T-cells and B220-positive B-cells did not 
differ considerably between genotypes, neither in colon nor in small intestinal tissue.  
b. Quantitative RT-PCR showed increased expression of a subset of inflammation-associated factors 
in colons of 7 to 8-week-old IKK2caIEChom mice compared to age matched IKK2casFL controls. (n ) 6) 
c. Increased amount of mRNA from inflammatory mediators detected by quantitative RT-PCR in the 
ileum of 7 to 8-week-old IKK2caIEChom mice. (n ) 6) 
Scale bars represent 50 $m 
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Quantitative real time PCR (qRT-PCR) analysis on mRNA from proximal colon and 
ileum revealed increased expression of various inflammatory cytokines and 
chemokines in IKK2caIEChom mice (Fig. 9b and 9c). TNF mRNA was produced at 
much higher levels than in control tissue and Ccl20, a chemokine involved in the 
recruitment of Th17 and dendritic cells, showed massively increased expression in 
both proximal colon and ileum from IKK2ca-expressing mice. Other pro-inflammatory 
mediators such as Cxcl-16, Cxcl-10, IL-1", and IL-23p19 were also produced at 
higher levels than in control tissue, indicating that IKK2caIEChom mice display clear 
signs of intestinal inflammation that affects both the colon and the small intestine. 
Interestingly, mRNA levels of inflammatory molecules such as IL-6 and cyclo-
oxygenase 2 (Cox2), two NF-!B target genes that have a well-established role in 
intestinal inflammation, were not increased in IKK2caIEChom intestines. This indicates 
that intestinal epithelial restricted expression of IKK2ca results in the establishment of 
an inflammatory state in the colon and the small intestine that is characterized by the 
production of a very defined cytokine pattern.  
 
Gene expression analysis on RNA isolated from IECs showed that these cytokines 
were produced mainly by the IKK2ca-expressing intestinal epithelium (Fig. 10). 
IKK2ca-expressing colon and small intestinal IECs produced higher mRNA levels of 
Ccl20, as observed also in mRNA derived from whole colon or small intestinal tissue 
from IKK2caIEChom mice (Brand, 2009; Schutyser et al., 2003). However, at the same 
time mRNA levels of other epithelial-derived chemokines such as Ccl25 and Ccl28 
were not increased in IECs from IKK2caIEChom mice.  
 
Furthermore, Reglll' was expressed at higher levels in colonic IECs from 
IKK2caIEChom mice (Fig. 10a). Reglll' is a C-type lectin with bactericidal functions that 
is secreted by Paneth cells of the small intestine and by epithelial cells of the colon 
(Ogawa et al., 2003). Its expression is induced by microbiota and is elevated under 
inflammatory conditions in IBD patients (Cash et al., 2006; Strober, 2006). The 
upregulation of Reglll' might indicate that the colonic epithelium of IKK2caIEChom mice 
is more responsive to the intestinal flora and induces the expression of a molecule 
involved in controlling bacterial outgrowth. 
 
Therefore quantitative RT-PCR analysis showed that expression of IKK2ca in the 
intestinal epithelium of mice and concomitant persistent activation of NF-!B does not 
result in uncontrolled and unselective expression of NF-!B target genes. Instead, a 
specific cytokine and chemokine expression pattern is established, leading to 
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increased recruitment of myeloid cells in the colon and small intestine of young 
IKK2caIEChom mice. 
 
Figure 10  Elevated expression of inflammatory mediators in intestinal epithelial cells of 
IKK2caIEChom mice 
a. A selective upregulation of epithelial cell derived inflammation-associated mediators was detectable 
by quantitative RT-PCR in colon IECs from IKK2caIEChom mice when compared to controls. (n = 5) 
b. Differential expression of inflammatory molecules as assessed by RT-PCR analysis in small 
intestinal epithelial cells of IKK2caIEChom mice. (n = 5) 
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3.2 Expression of IKK2ca in the intestinal epithelium increases sensitivity to 
DSS-induced colitis and strongly enhances AOM-induced colon cancer 
development 
It has been reported that deletion of either IKK2 or p65 in the intestinal epithelium 
renders mice more sensitive to DSS-induced colitis (Greten et al., 2004; Steinbrecher 
et al., 2008). Increased colitis severity in these mouse models is thought to result 
from the lack of anti-apoptotic functions exerted by NF-!B activation in the intestinal 
epithelium, since it was shown that DSS induced more extensive cell death of IECs in 
IKK2IEC-KO and p65IEC-KO mice (Greten et al., 2004; Steinbrecher et al., 2008). We 
therefore reasoned that persistent NF-!B activation as achieved by IKK2ca 
expression in IECs might prevent DSS-induced colitis. In order to investigate whether 
IKK2caIEChom mice were indeed protected from DSS-mediated colonic inflammation, 
IKK2caIEChom and IKK2casFL mice were given 2% DSS in the drinking water for six 
days and were provided with another two days of regular drinking water prior to 
sacrifice. Surprisingly, IKK2caIEChom mice responded to the DSS treatment with a 
much more pronounced loss of bodyweight than control animals (Fig. 11a). DSS-
elicited diarrhoea occurred much earlier in IKK2ca-expressing mice and was 
furthermore accompanied by the presence of blood in the stool, indicative of 
intestinal damage and bleeding, resulting in a heightened stool score compared to 
control animals (Fig. 11a).  
 
Histological analysis of the colon from mice sacrificed at day 8 of the treatment 
protocol revealed more pronounced tissue damage in IKK2caIEChom mice. Even 
though control mice exhibited mucosal ulceration and immune cell infiltration (Fig. 
11b), epithelial ulceration was more severe in IKK2ca-expressing animals resulting in 
an almost complete lack of crypt structures (see Fig. 11b). In addition, IKK2caIEChom 
mice harboured large immune cell infiltrates in the distal colon that could not be 
detected in control animals. Quantitative RT-PCR analysis of whole tissue mRNA 
from the distal colon revealed elevated expression levels of inflammatory cytokines 
and chemokines such as TNF, IL-1", MCP-1 and Cxcl-1 (Fig. 11c). These results 
show that IKK2caIEChom mice exhibit increased mucosal damage and enhanced 
intestinal inflammation upon DSS-induced colon injury than control mice. Therefore, 
persistent activation of the IKK2/NF-!B pathway in epithelial cells does not protect 
from DSS-mediated colitis development but rather sensitises mice to DSS-induced 
injury.  
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Figure 11   IKK2caIEChom mice exhibited increased sensitivity to DSS-induced colitis 
a. DSS-feeding of IKK2caIEChom mice resulted in a more pronounced loss of bodyweight than in control 
IKK2casFL animals, indicative of increased susceptibility to DSS-induced colitis. IKK2caIEChom mice 
developed a higher stool score (combined diarrhoea and intestinal bleeding score) than IKK2casFL 
mice when treated with 2% DSS in the drinking water. (n = 10) 
b. IKK2caIEChom mice showed more extended tissue damage in the colonic mucosa on day 8 of DSS 
treatment than IKK2casFL controls. The colonic mucosa of IKK2caIEChom mice displayed more severe 
immune cell infiltration and increased epithelial erosion. 
c. mRNA levels of pro-inflammatory molecules were increased in distal colon tissue of IKK2caIEChom 
mice upon DSS ingestion, when compared to IKK2casFL control mice.  
(n = 5 for naïve mice, n = 10 for DSS treated mice on day 8) 
Scale bars represent 50 $m 
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To assess the in vivo role of epithelial IKK2/NF-!B activation in AOM/DSS induced 
colorectal cancer development, IKK2caIEChom and age-matched IKK2casFL mice were 
subjected to an AOM/DSS treatment. Mice were injected intraperitoneally with 10 
mg/kg bodyweight of the procarcinogen AOM and were immediately thereafter 
administered with DSS-containing drinking water. Since IKK2caIEChom mice showed 
an increased sensitivity to DSS-induced mucosal injury, all mice were fed 1,5% DSS 
through the drinking water for three days only. Whereas IKK2casFL mice did not show 
considerable reduction of bodyweight, IKK2caIEChom mice exhibited a pronounced 
loss of bodyweight during these first days of the treatment (Fig. 12a). At the same 
time IKK2caIEChom mice showed severe intestinal bleeding and developed diarrhoea, 
which manifested in a heightened stool score (Fig. 12a). This elevated stool score of 
IKK2caIEChom mice persisted also after they were provided again with regular drinking 
water. Furthermore IKK2caIEChom mice experienced difficulties to recover from the 
DSS-induced mucosal insult, as shown by the slow rate of weight gain after removal 
of DSS. Although most AOM/DSS treatment protocols provide mice with several 
consecutive cycles of DSS feeding, the strong response of IKK2caIEChom mice to the 
first days of DSS-administration prompted us not to give any additional DSS to the 
mice until the end of the experiment (day 65). Since some IKK2caIEChom mice had lost 
more than 25% of their bodyweight and were moribund, they were sacrificed during 
the first 14 days of the treatment to avoid unnecessary suffering.  
 
Endoscopic analysis performed on day 26 of the treatment (3 weeks after the 
removal of DSS) revealed that IKK2casFL mice did not show signs of colitis and tissue 
damage and therefore had a low MEICS (Fig. 12b). In contrast, IKK2caIEChom mice 
exhibited a higher MEICS reflecting severe colonic inflammation, indicating that these 
animals were not able to recover from the initial DSS-induced inflammation. A final 
endoscopy performed prior to sacrifice on day 65 of the experiment showed that 
IKK2caIEChom animals had developed multiple tumours in the distal region of the 
colon, whereas control animals did not exhibit endoscopically detectable alterations 
in this area of the large intestine (Fig. 12c). The elevated MEICS assigned to 
IKK2caIEChom mice most probably also reflects the tumour-associated inflammation 
that is known to accompany tumour development. 
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Figure 12   Pronounced AOM/DSS-induced tumour development in IKK2caIEChom mice 
a. An AOM/DSS protocol including one intraperitoneal injection of 10 mg/kg bodyweight AOM and 3 
days of 1,5% DSS fed ad libidum resulted in loss of bodyweight in IKK2caIEChom but not in IKK2casFL 
animals. Diarrhoea and intestinal bleeding occurred in IKK2caIEChom but not in control mice at the 
beginning of the experiment. (n ) 9) 
b. Endoscopy on day 26 of the treatment revealed inflammation in the distal colon of IKK2caIEChom 
mice, reflected in a heightened MEICS. (n ) 6) 
c. Endoscopic examination on day 65 exhibited signs of inflammation and tumour growth in the distal 
colon area of IKK2caIEChom mice and a lack of lesions in IKK2casFL animals. Representative endoscopic 
images of distal colons show tumours in IKK2ca-expressing animals and healthy appearance of distal 
colons in IKK2casFL controls. (n ) 6) 
d. Histological evaluation of colons after AOM/DSS treatment revealed the presence of broad based 
adenomatous lesions in IKK2caIEChom mice but not in controls. In more severely affected IKK2caIEChom 
animals invasive adenocarcinomas were identified by invasion of epithelial tissue into the submucosa, 
indicative of carcinoma development.  
e. Immunofluorescent staining for FLAG shows that tumourous epithelial tissue in IKK2caIEChom mice 
produced FLAG-IKK2ca.  Scale bars represent 50 $m 
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Histological evaluation of colon tissue did not reveal signs of lesion development in 
control mice, indicating that the applied protocol was to mild to induce 
tumourigenesis in these mice (Fig. 12d). In contrast, IKK2caIEChom mice had 
developed multiple broad based colonic lesions classified as advanced stage, 
mucus-producing adenomas. Interestingly, we also observed two IKK2caIEChom mice 
displaying events of crypt invasion into the submucosa  (Fig. 12d right panel). 
Invasion of epithelial cells into the submucosa does not occur in adenomas, but 
happens in lesions that have advanced to the adenocarcinoma state. Therefore, 
AOM/DSS treatment also leads to adenocarcinoma development in the most 
severely affected IKK2caIEChom mice. 
 
Importantly, immunofluorescent staining for FLAG on colon tissue of AOM/DSS-
treated IKK2caIEChom mice indicated that also dysplastic tumour epithelium expressed 
FLAG-tagged IKK2ca and thus had not escaped Cre-mediated induction of IKK2ca 
expression (Fig. 12e). 
 
These results therefore show that a mild AOM/DSS tumour protocol was sufficient to 
induce pronounced tumour growth (adenomatous lesions) and development of 
malignant adenocarcinomas in IKK2caIEChom mice, but was not strong enough to 
trigger a similar tumourigenic response in control mice. Therefore the expression of 
constitutively active IKK2 in the intestinal epithelium renders mice much more 
sensitive to AOM/DSS-induced tumour incidence and progression. 
 
The above used AOM/DSS tumour induction protocol depends on inflammation-
mediated promotion of tumour growth. Since IKK2caIEChom mice exhibited an 
increased susceptibility to DSS-induced intestinal inflammation, the enhanced 
tumourigenesis observed upon AOM/DSS treatment in these animals most probably, 
at least partially, resulted from increased and sustained colonic inflammation. In 
order to uncover potential cell intrinsic functions of IKK2ca in tumour development, 
we applied a chemically inducible tumour protocol that does not require inflammation 
for driving tumour growth. For this experiment mice were injected on a weekly basis 
with 10 mg/kg AOM for five consecutive weeks (Fig. 13). Using this protocol, wild-
type C57Bl/6 mice normally show colonic tumour formation 30 weeks after the first 
AOM-injection (Neufert et al., 2007). Because 12 weeks after the first AOM injection 
most IKK2caIEChom mice appeared sick and displayed diarrhoea as well as loss of 
bodyweight, the animals were endoscopised already at week 13 and sacrificed 
thereafter. Endoscopic analysis revealed that all IKK2caIEChom 
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multiple colonic tumours, whereas none of the IKK2casFL mice displayed 
endoscopically detectable tumours. Histological sections revealed thickening of the 
colonic mucosa and confirmed the presence of big hyperplastic lesions with 
dysplastic crypts embedded in a reactive stroma in IKK2caIEChom mice (Fig. 13 left 
panel). Such lesions were found exclusively in IKK2caIEChom mice, as none of the 
control mice had developed tumours. Whereas the small intestine of AOM-injected 
control mice appeared normal, histological examination of the distal small intestine of 
IKK2caIEChom mice revealed the presence of hyperplastic lesions (Fig. 13 right panel). 
While ileal crypts were elongated, indicating hyperplasia, ileal villi of IKK2caIEChom 
mice were shortened and in some areas sparse. Furthermore, some crypts consisted 
of more than one epithelial cell layer, which is a sign for epithelial dysplasia. Overall 
the mucosal tissue was thickened and the lamina propria surrounding aberrantly 
formed crypt structures contained many inflammatory cells (see Fig. 13).  
 
Figure 13   Repetitive AOM-administration triggered early tumour development in IKK2caIEChom 
mice 
Five weekly injections with 10 mg/kg bodyweight AOM resulted in tumour growth in colons of 
IKK2caIEChom mice 13 weeks after the first injection. Wild-type mice did not display colon tumour 
growth under the same experimental conditions. The small intestine of IKK2caIEChom mice also showed 
histological alterations after this treatment. Whereas IKK2casFL mice displayed a regular small 
intestinal tissue structure, in IKK2caIEChom mice villi were shortened, crypts were hyperplastic and the 
small intestinal mucosa was inflamed and thickened. (n ) 8) 
Scale bars represent 50 $m 
 
These results thus show that IKK2caIEChom mice develop colon tumours upon 
repetitive AOM challenge at a time point when control animals had not developed 
any lesions yet. Furthermore, lesions occurred also in the small intestine of 
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IKK2caIEChom mice, a part of the intestinal tract that is normally not affected by AOM 
treatment. 
 
3.3 Strong cooperativity between Wnt- and IKK2/NF-!B signalling in 
intestinal tumourigenesis 
Mutations leading to activation of the Wnt-pathway are thought to be involved in 
intestinal cancer development in both humans and mice (Barker and Clevers, 2000). 
Accordingly, AOM-induced tumourigenesis in rodents was shown to be initiated by 
mutations mostly affecting "-catenin, the central player in the Wnt-signalling pathway, 
and thereby lead to its stabilisation (Greten et al., 2004; Takahashi and 
Wakabayashi, 2004; Tanaka et al., 2003).  
 
Since IKK2caIEChom mice exhibited increased tumour formation in response to AOM-
treatments, we sought to address the effect of IKK2ca in Wnt-induced intestinal 
tumour development. For this purpose, we used a genetic mouse model of intestinal 
tumourigenesis expressing a truncated version of the tumour suppressor Apc. The 
coding sequence of the Apc gene in these mice is interrupted by insertion of a Neo-
cassette after amino acid 1638 and therefore these mice are referred to as 
Apc1638N. Mice that express the mutant Apc1638N allele in a heterozygous manner 
(Apc1638N homozygous mice are embryonically lethal) spontaneously develop 
intestinal lesions especially in the proximal part of the small intestine at an age of 5 to 
6 months (Fodde et al., 1994). Lesions in the colon are rare and were reported to 
occur only in one-year-old Apc1638N animals (Fodde et al., 1994). For our studies 
we generated Apc1638N mice that expressed IKK2ca in IECs in a heterozygous 
manner (Apc1638N/IKK2caIEChet).  
 
Whereas the colon of 16-week-old Apc1638N/IKK2casFL mice on endoscopic 
examination did not show signs of tumour development, every monitored 
Apc1638N/IKK2caIEChet mouse harboured at least one clearly detectable distal colon 
tumour. Apc1638N/IKK2caIEChet mice had a higher MEICS when compared to 
Apc1638N/IKK2casFL, IKK2casFL and IKK2caIEChet mice, which could be caused by 
tumour associated inflammation (Fig. 14a). Ex vivo examination revealed tumour 
growth also in the proximal colon area in most Apc1638N/IKK2caIEChet animals (Fig. 
14b). None of the control mice (Apc1638N/IKK2casFL, IKK2casFL and 
IKK2caIEChetmice) harboured macroscopically visible tumours in any part of the large 
intestine.  
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Figure 14   Accelerated tumour formation in Apc1638N/IKK2caIEChet mice 
a. Endoscopy of distal colon did not demonstrate inflammation or presence of tumours in 4-month-old 
Apc1638N/IKK2casFL mice (n = 6). Apc1638N/IKK2caIEChet mice (n = 11) exhibited a moderately 
increased MEICS due to tumour development and inflammation. IKK2casFL (n = 9) and IKK2caIEChet    
(n = 11) mice appeared healthy. 
b. Macroscopic examination of colons revealed tumour growth in all Apc1638N/IKK2caIEChet mice 
examined at 16 to 17 weeks of age (n = 11), whereas Apc1638N/IKK2casFL (n = 6), IKK2caIEChet         
(n = 11) and IKK2casFL mice (n = 9) did not have lesions. 
c. The proximal halves of small intestines of all monitored four-month-old Apc1638N/IKK2caIEChet mice 
contained polypoid lesions (n = 11). Only 2 out of 6 Apc1638N/IKK2casFL mice had developed one or 
two small polyps in the duodenal region of the small intestine. IKK2caIEChet (n = 11) and IKK2casFL mice 
(n = 9) did not have small intestinal lesions. 
d. Histological evaluation of colon and small intestinal sections from Apc1638N/IKK2caIEChet mice 
confirmed the presence of adenomatous tumours in both tissues. Lesions in the colon displayed 
hyperplastic, as well as dysplastic crypt growth characterized by a multilayered epithelium and loss of 
differentiated cells. Small intestinal polyps harboured hyperplastic and also dysplastic, aberrantly 
shaped crypts with epithelial stratification and loss of differentiation. No tumourous lesions were found 
in colon sections of any other genotype, and the small intestines appeared normal. 
Scale bars represent 50 $m 
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The small intestine of 16 to 17-week-old mice was opened longitudinally and the 
whole tissue was screened for macroscopically visible polyps. As expected, none of 
the IKK2casFL and IKK2caIEChet mice had lesions in the small intestine (Fig. 14c). 
While 2 out of 6 Apc1638N/IKK2casFL mice contained 1 or 2 small polyps in the 
proximal duodenal part of the small intestine, all 11 Apc1638N/IKK2caIEChet mice had 
developed multiple clearly detectable polyps in the proximal half of the small intestine 
(Fig. 14c). This observation shows that heterozygous expression of IKK2ca in IECs 
strongly accelerates and amplifies tumour development in the small intestine of 
Apc1638N mice and furthermore leads to tumour growth also in the colon.  
 
Histological examination of swiss-rolled colon tissue of Apc1638N/IKK2caIEChet mice 
confirmed the presence of lesions growing both in the distal and proximal part of the 
colon. Colonic tumours in these mice were characterized by hyperplastic elongated 
crypts and aberrantly shaped crypt structures growing on top of each other (Fig. 
14d). Dysplastic crypts were identified by lack of differentiation and epithelial 
stratification, meaning that crypts were composed of multiple layers of epithelial cells. 
In addition, lesions were infiltrated with immune cells and occasionally developed 
submucosal oedema. The colonic mucosa of Apc1638N/IKK2casFL mice appeared 
normal with no signs of altered crypt structures. No marked differences were 
observed in the histological appearance of colons from IKK2casFL and IKK2caIEChet 
mice (Fig. 14d). In some cases though, IKK2caIEChet mice showed confined immune 
cell infiltrations in the mucosa (see Fig. 14d, colon). This occurred in a patchy, 
discontinuous fashion and did not lead to an alteration of the epithelial tissue 
architecture. 
 
Polyps located in the proximal small intestine of 4-month-old Apc1638N/IKK2caIEChet 
animals displayed alteration of crypt villus organisation, with aberrantly formed crypts 
expanding to the villus area of the intestine (Fig. 14d). Enlarged crypts exhibiting 
epithelial stratification and loss of differentiation were growing on top of each other 
and made a major contribution to the polyp mass. Polyps additionally displayed 
immune cell infiltrates, which most probably reflected tumour associated 
inflammation. These kinds of lesions were not found in the small intestine of 
IKK2caIEChet or IKK2casFL mice. These results provide experimental evidence that 
expression of IKK2ca in the intestinal epithelium of Apc1638N mice strongly 
synergized with Wnt-induced tumour formation, resulting in much earlier and more 
aggressive polyp formation in the intestine of Apc1638N/IKK2caIEChet mice. 
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Immunohistochemical staining for Ki67 revealed increased proliferation of IECs in 
hyperplastic and dysplastic crypts in Apc1638N/IKK2caIEChet mice (Fig. 15a). Colon 
tumours in Apc1638N/IKK2caIEChet mice exhinbited strongly enhanced proliferation, 
as most of the epithelial cells in the tumours were Ki67 positive. Also small intestinal 
polyps displayed increased proliferative activity, since Ki67 positive IECs were 
identified throughout the lesions including the mucosal area towards the lumen (Fig. 
15a). The proliferation pattern of IECs in Apc1638N/IKK2casFL mice in the colon and 
the small intestine was not altered when compared to control IKK2casFL mice (Fig. 
15a). Occasionally IKK2caIEChet mice showed scattered areas with increased IEC 
proliferation in colon and small intestinal tissue. This manifested in an extension of 
Ki67 positive cells towards the lumen. However overall the Ki67 staining pattern in 
both parts of the intestine did not differ considerably between IKK2caIEChet and 
IKK2casFL mice at 4 months of age (Fig. 15a). 
 
In order to address the level of "-catenin activation in intestinal lesions an 
immunostaining for Sox9, a transcription factor encoded by a "-catenin target gene, 
was performed. Sox9 normally is expressed at high levels in stem cells, in Paneth 
cells and in some subtypes of enteroendocrine cells, but is expressed to a lesser 
extent in non-differentiated TA cells. Almost all IECs in tumours growing in the colon 
of Apc1638N/IKK2caIEChet mice were positive for Sox9, suggesting that in these cells 
"-catenin was activated (Fig. 15b). Sox9 was also detected in IECs close to the 
apical part of dysplastic crypts, indicating that these cells had not undergone terminal 
differentiation and had maintained their proliferating capacities. This Sox9 expression 
pattern is in accordance with the Ki67 staining observed in these areas. Accordingly, 
small intestinal lesions of Apc1638N/IKK2caIEChet mice also exhibited an expansion of 
Sox9 expressing cells, suggesting that the "-catenin pathway was active in these 
cells as well. Overall the Sox9 and Ki67 staining patterns in tumourous tissues 
correlated, indicating an increase in "-catenin activity and concomitantly elevated 
proliferation capacity. 
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Figure 15   Increased proliferation and "-catenin activation in tumours of Apc1638N/IKK2caIEChet 
mice 
a. Immunohistochemical staining for the proliferation marker Ki67 on colon and small intestinal 
sections revealed normal Ki67 staining patterns in both tissues of Apc1638N/IKK2casFL, IKK2caIEChet 
and IKK2casFL animals. However, Apc1638N/IKK2caIEChet mice showed increased epithelial 
proliferation in lesions of the colon and the small intestine. 
b. Immunostaining for Sox9 revealed the presence of Sox9 expressing cells at the lower part of 
colonic crypts in both IKK2casFL and IKK2caIEChet animals. The same staining pattern was also visible 
in Apc1638N/IKK2casFL mice, whereas colon tumours in Apc1638N/IKK2caIEChet mice displayed strong 
Sox9 staining in all IECs. In the small intestine of IKK2casFL, IKK2caIEChet and Apc1638N/IKK2casFL 
mice Sox9 staining was restricted to the crypt area. Most epithelial cells of small intestinal polyps in 
Apc1638N/IKK2caIEChet mice were positive for Sox9. Scale bars represent 50 $m 
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Figure 16   Early tumour development in Apc1638N/IKK2caIEChom mice 
a. At 11 weeks of age Apc1638N/IKK2caIEChom mice exhibited advanced tumour growth in the colon. 
Also 8-week-old animals harboured dysplastic lesions in the proximal colon area. 
b. Polyp formation in the small intestine was strongly accelerated in 8-week-old 
Apc1638N/IKK2caIEChom mice, resulting in severe crypt hyperplasia and ectopic crypt formation 
throughout the small intestine. 
Scale bars represent 50 $m 
 
When IKK2ca expression levels in IECs from Apc1638N mice were even more 
increased by generating Apc1638N/IKK2caIEChom mice, the development of 
tumourous lesions was further accelerated. Already at an age of 8 weeks the colon of 
Apc1638N/IKK2caIEChom animals contained hyperplastic crypts and also dysplastic 
tumourous tissue, whereas at 11 weeks of age tumour size and numbers in the colon 
    Results 
 71 
had further increased (Fig. 16a). The small intestine was more severely affected by 
polyp formation in these Apc1638N/IKK2caIEChom mice. Throughout the whole small 
intestine crypts were growing on top of each other, indicative for strongly enhanced 
proliferation and a lack of tissue organisation (Fig. 16b). Occasionally crypts crowded 
the basal part of the mucosa and formed clusters surrounded by few inflammatory 
cells and fibroblasts. Villi were short and sometimes contained crypt structures, 
indicating ectopic crypt formation (Fig. 16b). The latter culminated in crypt structures 
that grew in villi, generating so called crypt cysts, where IECs proliferate outside the 
regular crypt area. 
 
3.4 Spontaneous intestinal tumour development accompanied by strong 
 inflammation in aged IKK2caIEChom mice 
The described in the previous section showed that epithelial specific expression of 
IKK2ca strongly enhanced tumourigenesis in different inflammation-dependent, 
carcinogen-induced and genetic models of intestinal cancer. These results suggest 
that constitutively increased IKK2 activity in IECs affects fundamental cellular 
processes important for intestinal carcinogenesis to promote tumour development. 
To address whether constitutively increased IKK2 activity was sufficient to induce 
spontaneous development of intestinal tumours, a cohort of IKK2caIEChom and 
littermate control mice ageing for 12 months was followed and tumour development 
was assessed by endoscopy and post-mortem macroscopic and histological 
examination.  
 
At different time points during their lifetime a fraction of these animals became sick. 
Diseased mice suffered from diarrhoea and weight loss. More severely affected mice 
developed a rectal prolapse and intestinal bleeding as assessed on the presence of 
blood in loose stool. Rectal prolapse developed at random ages in IKK2caIEChom 
mice, with the youngest mouse displaying prolapse formation at 7 weeks of age. 
Mice with rectal prolapse were sacrificed and post-mortem analysis revealed, 
irrespective of their age, severe inflammation in the colonic mucosa. Cross sections 
of colon tissue revealed areas that were dramatically thickened and had a tumour-
like appearance (Fig. 17a). These regions harboured aberrantly shaped hyperplastic 
and even dysplastic crypt structures (Fig. 17a and 17b), indicating that the early 
inflammatory phenotype of young mice had progressed into epithelial alterations in 
the colon. 
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Figure 17   Epithelial dysplasia in the colon of IKK2caIEChom mice with rectal prolapse  
a. Small power magnification of histological cross-sections from the colon depicting pronounced 
thickening of one part of the mucosa occurring in IKK2caIEChom mice that had developed a rectal 
prolapse.  
b. High power magnification images reveal the presence of complex crypt structures (left panel) and 
epithelial dysplasia (right panel) in colon tissue from IKK2caIEChom animals with a rectal prolapse. 
Scale bars represent 50 $m 
 
IKK2caIEChom mice that had not developed a rectal prolapse and reached the age of 
at least 48 weeks were subjected to endoscopic examination. Endoscopy revealed 
inflammation of the distal colon in most monitored IKK2caIEChom mice, whereas age 
matched and cohoused control animals were healthy (Fig. 18a). Diseased animals 
showed bowel wall thickening, perturbations in the vessel structure and loose stool. 
Furthermore, the mucosal surface appeared granular. Endoscopy revealed the 
presence of tumour-like lesions in the distal part of the colon in about 50% of these 
old mice (Fig. 18b). Histological examination of colons from aged IKK2caIEChom mice 
demonstrated the presence of tumourous lesions not only in the distal area, but also 
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in the proximal part of the colon. The colon was inflamed, as reflected by infiltration of 
immune cells both in the mucosa and submucosa (Fig. 18c). Importantly, inflamed 
colons exhibited epithelial hyperplasia as identified by crypt elongation and the 
presence of aberrantly formed crypt shapes (denoted hyperplasia in colon 
histological sections of IKK2caIEChom mice in Fig. 18c). Hyperplastic colonic crypts 
had developed protrusions that grew out sideways from the crypt axis and resulted in 
complex crypt structures. Furthermore, about 30% of the aged IKK2caIEChom mice 
harboured colonic crypts that showed lack of differentiation and stratified epithelium 
(denoted as dysplasia in colon histological sections of IKK2caIEChom mice in Fig. 18c). 
These crypts were embedded in a so-called “reactive stroma”, which is a mucosa 
containing many inflammatory cells and myofibroblasts. Myofibroblasts are activated 
fibroblasts that produce various cytokines, chemokines and growth factors and that 
are thought to sustain inflammation and promote proliferation of adjacent cells 
(Franco et al., 2010). These myofibroblasts were identified by their elongated shape 
and reddish colour due to the strong eosin staining intensity of myofibres (indicated in 
the pop-up figure by a white arrow-head in Fig. 18c). 
 
Also the small intestine of aged IKK2caIEChom mice exhibited signs of intestinal 
disease. The small intestine was enlarged, which is reflected in a larger diameter of 
the tissue visible on histological cross sections in Fig. 18d. Inflammatory cell 
infiltrates in the mucosa were located around the crypts and crypts arranged 
themselves on top of each other, indicative of enhanced proliferation (denoted as 
hyperplasia and adenoma in small intestine histological sections of IKK2caIEChom mice 
in Fig 18d). In 40% out of the analysed one-year-old IKK2caIEChom mice adenomatous 
lesions had developed either in the proximal or in the distal part of the small intestine. 
These adenomas harboured crypts that stacked on top of each other and had lost the 
regular pattern of crypt arrangement visible in control mice (see Fig. 18d). Such 
areas displayed loss of villus structures that were replaced by enlarged crypts 
growing in a disorganised way. Despite the pronounced hyperplasia of the small 
intestinal mucosa, differentiation of epithelial cells was not completely abrogated. 
Adenomatous crypts gave rise to goblet cells and epithelial stratification was rare. 
However, Paneth cells, which like goblet cells belong to the secretory cell lineage, 
were absent from adenomatous lesions (see adenoma in Fig. 18d). Therefore lesions 
identified in the small intestines of IKK2caIEChom mice were less advanced than colon 
tumours. 
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Figure 18   Spontaneous inflammation and intestinal tumourigenesis in old IKK2caIEChom mice 
a. Endoscopy of aged mice () 48 weeks) revealed heightened MEICS in IKK2caIEChom mice due to 
inflammation in the distal colon, as reflected in bowel wall thickening, altered vascularisation structure 
and granularity of the mucosa, indicating intestinal disease. (n)18) 
b. Representative endoscopic images depicting tumourous structures with distinctive vascularisation 
found in the distal colon of 50% of examined aged IKK2caIEChom mice. Age matched IKK2casFL control 
animals did not show signs of inflammation or tumour growth.  
c. Histological analysis of colon tissue from IKK2caIEChom mice revealed the presence of tumours 
characterized by a thickened mucosa, crypt hyperplasia and strong inflammation. More severely 
affected animals also harboured dysplastic crypt structures surrounded by inflammatory cells. White 
arrows indicate dysplastic IECs and myofibroblasts. 
d. Histological examination of small intestines of IKK2caIEChom mice revealed inflammation also in this 
part of the gastrointestinal tract. Hyperplasia was identified by an increase in crypt numbers. 
Adenomas were present in more severely affected mice. 
Scale bars represent 50 $m 
    Results 
 75 
Immunostaining for Ki67 revealed an increased number of proliferating epithelial cells 
in the tumourous colonic mucosa of IKK2caIEChom mice (Fig. 19a). All hyperplastic 
and dysplastic IECs in IKK2caIEChom mice were positive for Ki67. Furthermore, apical 
IECs lining the lumen also expressed Ki67, indicating that these cells had maintained 
their proliferating capacities and presumably had not undergone terminal 
differentiation. In age matched IKK2casFL animals proliferating cells were restricted to 
the transit-amplifying region of colonic crypts (Fig. 19a).  
 
Also small intestinal crypts of IKK2caIEChom mice exhibited an increased level of 
proliferation, as judged from the Ki67 staining pattern. The base of small intestinal 
crypts from control animals harbours the terminally differentiated Paneth cells that do 
not produce Ki67. Therefore, cells located at the crypt base are mostly negative for 
proliferation markers such as Ki67. The actively cycling Lgr5-positive stem cells, that 
do express Ki67, are thought to be responsible for some Ki67 positive nuclei present 
at crypt bases (Barker et al., 2007). This staining pattern is reflected in control small 
intestinal cross sections, as seen in Fig. 19a, where few Ki67 positive cells with 
elongated nuclei are located in between the Ki67 negative Paneth cells. In contrast, 
almost all crypt IECs from IKK2caIEChom mice were positive for Ki67, including the 
epithelial cells at the crypt base (Fig. 19a). 
 
The staining pattern for Sox9 was perturbed in lesioned areas of IKK2caIEChom mice, 
both in the colon and the small intestine (Fig. 19b). Similar to the Ki67 
immunohistochemistry, all IECs in hyperplastic colonic crypts strongly expressed 
Sox9. Also apical IECs at the very luminal part of the colonic mucosa were positive 
for this transcription factor that is indicative of "-catenin activity. In contrast, Sox9 
expression in IECs of one-year-old IKK2casFL mice was restricted to the lower two 
thirds of crypts. In the small intestine Sox9 producing IECs were visible throughout 
the adenomatous lesions of IKK2caIEChom mice, whereas in control tissue Sox9 
positive cells were restricted to crypts (Fig. 19b). 
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Figure 19   Increased proliferation and "-catenin activation in the intestinal epithelium of aged 
IKK2caIEChom mice 
a. Immunohistochemical analysis for Ki67 expression revealed heightened proliferative activity in 
lesions of the colon and the small intestine of aged IKK2caIEChom mice, indicating an expansion of the 
proliferating epithelial compartment. Age matched IKK2casFL mice displayed a normal staining pattern 
for Ki67 in both tissues. 
b. Staining for Sox9 showed increased expression of this factor in IECs of tumours in IKK2caIEChom 
mice, indicating increased "-catenin activity in these areas. Staining for Sox9 was restricted to the 
proliferating crypt area both, in the colon and the small intestine of wild-type controls. 
Scale bars represent 50 $m 
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These results show that epithelial restricted expression of constitutively active IKK2 is 
sufficient to induce tumour development in the colon and the small intestine of aged 
IKK2caIEChom mice. Tumourous lesions displayed enhanced activation of "-catenin as 
judged by increased levels of Sox9 expression and a concomitant increase in IEC 
proliferation.  
 
3.5 Increased stabilisation and activation of "-catenin in the intestine of 
 young IKK2caIEChom mice 
To understand the mechanisms underlying spontaneous tumour development in 
IKK2caIEChom mice, young IKK2caIEChom mice that had not developed lesions yet were 
analysed in more detail. Since we observed a strong cooperativity between IKK2ca-
expression and Wnt-signalling in tumour development, we assessed the status of b-
catenin activity in young IKK2caIEChom animals. IHC for "-catenin showed increased 
abundance of the protein in colonic IECs from 8-week-old IKK2caIEChom mice 
compared to age matched controls (Fig. 20a). For this "-catenin IHC protocol, colon 
sections from IKK2caIEChom and IKK2casFL mice were cut at the same thickness and 
placed on the same slide in order to make sure that control and transgenic tissue 
was treated the same way during the staining procedure and was exposed to 3,3'-
Diaminobenzidine (DAB) for the same time during the enzymatic staining reaction. 
The observed difference in "-catenin levels on IHC was confirmed by Western Blot 
analzsis performed with protein extracts from colonic and small intestinal IECs (Fig. 
20b and 20c). IKK2caIEChom mice showed higher protein levels of "-catenin in 
cytoplasmic and nuclear fractions of colon IECs when compared to IKK2casFL 
controls. Importantly also protein levels of the active, N-terminally not phosphorylated 
and therefore degradation resistant form of "-catenin, were increased in both cell 
fractions from IKK2ca-expressing colonic IECs (Fig. 20b). The level of total b-catenin 
protein was also elevated in primary small intestinal IECs as seen in Fig. 20c, where 
crude protein extracts were probed for "-catenin expression. Higher amounts of 
nuclear as well as active "-catenin imply that IECs from young IKK2caIEChom mice 
have higher "-catenin transcriptional activity than control mice. 
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Figure 20   Increased levels of "-catenin and selective induction of "-catenin target genes in 
the intestine of young IKK2caIEChom mice 
a. Immunohistochemical staining for "-catenin revealed an increased abundance of "-catenin in colon 
IECs of 9-week-old IKK2caIEChom mice when compared to age matched IKK2casFL littermates.  
b. Western Blot analysis of nuclear and cytoplasmic extracts prepared from colon epithelial cells from 
8-week-old animals revealed increased amounts of "-catenin in cytoplasmic and nuclear fractions 
from IKK2ca-expressing IECs compared to protein extracts prepared from wild-type mice. Importantly, 
active N-terminally non-phosphorylated and therefore degradation resistant "-catenin accumulated at 
higher levels in cytoplasmic and nuclear extracts from colon IECs of IKK2caIEChom mice. 
c. Lysates of small intestinal IECs derived from IKK2caIEChom mice contained higher amounts of "-
catenin when compared to protein extracts from IKK2casFL control mice. 
d. Quantitative RT-PCR analysis did not reveal differential mRNA expression of various "-catenin 
target genes and Wnt-signalling components in colon IECs from 8-week-old IKK2caIEChom and 
IKK2casFL mice. (n = 5) 
e. Increased mRNA levels of a subset of "-catenin target genes were identified in colon and small 
intestinal tissue of IKK2caIEChom mice at 7 to 8 weeks of age when compared to age matched controls. 
MRNAs coding MMP7, Laminin '2 and L1CAM, that are known to be under the control of "-catenin, 
were produced at higher levels in IKK2caIEChom mice when compared to IKK2casFL controls. (n ) 6) 
Scale bars represent 50 $m 
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Despite these observations suggesting higher "-catenin transcriptional activity, 
quantitative RT-PCR did not reveal increased expression levels of a number of "-
catenin target genes such as c-myc, Cyclin D1 and Axin2 in colon IECs from 
IKK2caIEChom mice at eight weeks of age (Fig. 20d). However, some "-catenin 
regulated genes were expressed at higher levels in the intestine of IKK2caIEChom 
mice. Indeed, mRNA levels of MMP7 were increased in proximal colon tissue of 
IKK2caIEChom mice. Laminin '2 and L1CAM were higher in both the colon and the 
small intestine of IKK2caIEChom mice when compared to IKK2casFL controls (Fig. 20e). 
These results show that a subset of "-catenin regulated genes is expressed at higher 
levels in IKK2caIEChom animals, suggesting that in IKK2ca-expressing IECs the 
transcriptional activity of "-catenin is increased in a target gene specific manner. 
 
Since the Wnt-"-catenin signalling pathway is essential for maintaining IEC 
proliferation and since increased levels of "-catenin activity are indicative of 
enhanced proliferation, we stained intestinal tissue from 10-week-old mice for Ki67. 
In the colon of IKK2caIEChom mice Ki67 positive cells were expanded towards the 
lumen, indicating that the proliferating TA compartment was extended (Fig. 21a). In 
the small intestine differences between controls and IKK2caIEChom animals were even 
more obvious (Fig. 21a). As mentioned above, terminally differentiated Paneth cells 
that do not express Ki67 reside in ileal crypt bases, resulting in a lack of Ki67 staining 
in this area. Few Ki67 positive cells found in this region originate from stem cells, 
which do express nuclear Ki67. Whereas this staining pattern was seen in IKK2casFL 
mice, in IKK2caIEChom animals nearly all crypt cells were positive for Ki67. This 
increase in proliferating crypt cells is indicative for heightened "-catenin activation in 
IECs, correlating with the data shown in Fig. 20.  
 
Immunohistochemical staining for Sox9 was performed to evaluate "-catenin activity. 
Sox9 was produced in higher amounts in IECs of young IKK2caIEChom mice, as seen 
by increased Sox9 staining intensity in 10-week-old IKK2caIEChom mice on the one 
hand and by an extension of Sox9 producing cells in colonic crypts towards the 
apical part of the mucosa on the other hand (Fig. 21b). In the small intestine Sox9 is 
highly expressed in stem cells and in Paneth cells, whereas the expression level 
decreases in the TA compartment and disappears at the crypt-villus-junction, where 
IECs undergo terminal differentiation (Bastide et al., 2007; Blache et al., 2004). Some 
subtypes of enteroendocrine cells in the colon and the small intestine maintain 
nuclear Sox9 expression also upon differentiation (Bastide et al., 2007). At the crypt 
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base high levels of Sox9 mark stem cells with elongated and triangular shaped nuclei 
surrounded by a slim cytoplasmic margin. Paneth cells, which also show strong Sox9 
staining, are big cells that have a small roundish nucleus and a big amount of 
cytoplasm. In 10-week-old IKK2casFL mice these distinct cell type characteristics can 
be distinguished at the ileal crypt bases as depicted in Fig. 21b. In IKK2caIEChom mice 
though such discrimination between cell types is not possible. All IKK2caIEChom crypt 
bottom cells show strong Sox9 staining intensity and the morphological differences 
between the nuclei and the cell shapes cannot be appreciated. Therefore it seems 
that in young IKK2caIEChom animals either the stem cells are expanded and have 
displaced the Paneth cells, or Paneth cell precursors do not undergo differentiation 
and continue to proliferate. Alternatively, it is possible that TA cells that have 
extended towards the crypt bottom replaced Paneth cells and therefore in 
IKK2caIEChom mice occupy the crypt bases.  
 
In line with reduced Paneth cell numbers, MMP7 mRNA was expressed in lower 
amounts in the ileum of young IKK2caIEChom animals, as shown by quantitative RT-
PCR analysis (Fig. 21c). MMP7 is responsible for the activation of defensins, small 
anti-microbial factors that are also produced by Paneth cells (Keshav, 2006; 
Wehkamp and Stange, 2006; Wilson et al., 1995). Lower levels of MMP7 in the ileum 
of IKK2caIEChom mice point towards a Paneth cell defect that might lead to an 
impaired regulation of the intestinal microflora. 
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Figure 21   Enhanced proliferation and Sox9 expression in the intestine of young IKK2caIEChom 
mice 
a. Immunofluorescent staining for Ki67 indicated increased proliferation of IECs in the colon and the 
small intestine of IKK2caIEChom mice at 10 weeks of age. In IKK2caIEChom animals Ki67 positive 
epithelial cells were extended towards the colonic lumen when compared to IKK2casFL controls. In 
small intestinal crypts of IKK2casFL mice Ki67 marks the transit amplifying cells, whereas the crypt 
bases, which harbour terminally differentiated Paneth cells, are mostly negative for Ki67. All IECs in 
small intestinal crypts of IKK2caIEChom mice were positive for Ki67. 
b. Immunostaining for Sox9 revealed elevated Sox9 expression in the colon of 10-week-old 
IKK2caIEChom mice. In the small intestine Sox9 IHC allowed identification of Paneth cells and stem cells 
in IKK2casFL but not in IKK2caIEChom mice. 
c. Quantitative RT-PCR for MMP7 on distal small intestinal tissue revealed a reduction of MMP7 
mRNA in IKK2caIEChom mice compared to IKK2casFL controls, indicating reduced numbers of Paneth 
cells, which are the main producers of MMP7 in the small intestine of mice. (n ) 6) 
Scale bars represent 50 $m 
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3.6 Perturbation of stem cells in the intestine of young IKK2caIEChom mice 
Since the patterns of Sox9 and Ki67 expression observed in young IKK2caIEChom 
mice pointed towards a potential alteration of stem cell status, quantitative RT-PCR 
analysis was performed to assess the expression levels of stem cell associated 
factors in the colon and the small intestine of 7 to 8 week old mice. Quantitative RT-
PCRs revealed increased expression of Ascl2, Olfm4 and TnfRsF19 in the proximal 
colon of IKK2caIEChom mice compared to IKK2casFL controls (Fig. 22a). These factors 
have been shown to be exclusively produced by epithelial stem cells in the intestine 
(van der Flier et al., 2009) and therefore might point towards an altered state of this 
cell type in IKK2caIEChom mice. CD44, a receptor for hyaluronan acid (Goodison et al., 
1999), was reported to be expressed at high levels in crypt-base cells that still 
undergo cell divisions while its expression is down-regulated when these IECs 
differentiate (Wielenga et al., 1999). More recently CD44 has been shown to be a 
marker of human colon cancer stem cells (Dalerba et al., 2007). In colons of young 
IKK2caIEChom mice mRNA levels of CD44 were mildly elevated when compared to 
littermate controls, indicating that IKK2caIEChom mice harbour more undifferentiated, 
proliferating epithelial cells than control mice. Also the ileum of IKK2caIEChom mice 
produced higher amounts of mRNA’s encoding stem cell associated factors. Indeed, 
Ascl2, Bmi-1, and CD44 mRNA levels were significantly upregulated in the ileum of 
IKK2caIEChom mice (Fig. 22b). In contrast to the observed higher levels of Olfm4 in the 
colon, mRNA for this stem cell associated factor was not upregulated in the small 
intestine of IKK2caIEChom mice, indicating differential regulation of Olfm4 between 
colon and small intestine (compare Fig. 22a and 22b).  
 
Surprisingly, leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5 or G-
protein coupled receptor 49, Gpr49), which currently is the most widely accepted 
marker for intestinal epithelial stem cells, was not upregulated on mRNA level in the 
colon or in the small intestine of IKK2caIEChom mice (see Fig. 22A and 22b). Instead, 
in the colon of IKK2caIEChom mice Lgr5 was even expressed at significantly lower 
levels than in the colon of control mice (Fig. 22a). Furthermore, mRNA levels of 
CD133 (also known as prominin-1), which encodes a cell surface molecule in stem 
cells and their immediate descendants (Snippert et al., 2009), were also not altered 
in the intestine of IKK2caIEChom mice (compare Fig. 22a and 22b). 
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Figure 22   Increased expression of a subset of stem cell associated factors in the intestine of 
IKK2caIEChom mice 
a. and b. Quantitative RT-PCR analysis exhibited elevated expression of intestinal epithelial stem cell 
associated factors in the colon (a.) and the small intestine (b.) of IKK2caIEChom compared to IKK2casFL 
control mice. (n ) 6) 
c. Western Blot analysis of protein extracts from human colon cancer HCT116 cells transfected with 
plasmids coding for IKK2, IKK2ca or empty vector revealed an upregulation of Ascl2 protein in cells 
expressing IKK2ca. 
d. Quantitative RT-PCR showed that DLK1 mRNA was present in higher amounts in the colon and the 
small intestine of IKK2caIEChom mice when compared to IKK2casFL littermates. (n ) 6) 
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These data obtained by quantitative RT-PCR show that the mRNA levels of a 
number of stem cell associated factors are differentially expressed in IKK2caIEChom 
mice when compared to controls, suggesting that IKK2ca expression in IECs might 
directly affect crypt stem cells. 
 
In order to investigate whether IKK2ca-mediated NF-kB activation has a direct effect 
on expression of stem cell associated factors, HCT116 cells were transfected with 
plasmids coding for IKK2, IKK2ca, or vector controls. As revealed by Western Blot 
analysis, HCT116 cells transfected with IKK2ca coding plasmid showed increased 
Ascl2 protein levels (Fig. 22c). As expression of wild-type IKK2 did not result in 
elevation of Ascl2 protein amounts, expression levels of Ascl2 might correlate directly 
with IKK2 kinase activity and subsequent NF-kB activation. These experiments thus 
point towards a direct role for IKK2/NF-kB activation in inducing the production of 
Ascl2. 
 
In addition to these findings, quantitative RT-PCR for DLK1 (Drosophila homologue 
of Delta-like 1, also known as pre-adipocyte factor 1, Pref-1) revealed increased 
mRNA levels in both the colon and the small intestine of 7 to 8-week-old IKK2caIEChom 
mice (Fig. 22d). DLK1 is transcriptionally upregulated upon deletion of Apc and it 
prevents the differentiation of pre-adipocytes via upregulation of Sox9 (Dong et al., 
2004; Sansom et al., 2004; Wang and Sul, 2009) 
 
3.7 Activation of non-immune cells and DNA damage in the intestine of 
 IKK2caIEChom mice 
It has been shown that cells of the tumour microenvironment play an important role in 
sustaining tumour growth by producing cytokines, chemokines and growth factors 
(Coussens and Werb, 2002). Recent reports underscored the importance of 
fibroblasts in promoting tumour growth and expansion (Erez et al., 2010; Vermeulen 
et al., 2010). 
 
To check for the presence of activated fibroblasts we stained colon sections from 
IKK2caIEChom animals for #SMA (alpha smooth muscle actin), which is a marker 
specifically expressed by activated fibroblasts (also termed myofibroblasts) (Eyden et 
al., 2009). Control mice showed considerably fewer #SMA positive cells in the colonic 
mucosa than IKK2caIEChom mice (Fig. 23c). In an inflammatory and tumourous 
environment activation of fibroblasts and their subsequent differentiation into 
myofibroblasts occurs due to the presence of inflammatory cytokines such as TNF, 
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IL-1" and TGF-", all of which were produced at higher levels already in young 
IKK2caIEChom animals (see Fig. 9B and 9c). Therefore, immunohistochemical staining 
for #SMA was also performed on colon tissue from young IKK2caIEChom and 
IKK2casFL animals. As shown in Figure 23c the mucosa of IKK2ca-expressing mice 
harboured more #SMA positive myofibroblasts than colon tissue from controls. This 
finding indicates that increased IKK2/NF-kB activity in the intestinal epithelium of 
mice leads to activation not only of immune cells but also of fibroblasts in the 
surrounding stroma.  
 
For tumourigenesis it is crucial that tumour-initiating cells develop, which are largely 
independent from environmental cues and divide in a deregulated manner, a process 
also known as transformation. Transformation of cells occurs when mutations in 
oncogenes or tumour suppressor genes have taken place. DNA damage that occurs 
in inflammatory conditions due to increased ROS production can increase the 
probability of mutation incidence. In the course of a DNA damage response histone 
2A.X is phosphorylated, giving rise to the so-called 'H2A.X epitope that is used as a 
marker for DNA damage (Kinner et al., 2008). To investigate the amount of DNA 
damage in IECs of IKK2caIEChom mice, an IHC staining for 'H2A.X was performed. 
Whereas differences between control animals and IKK2caIEChom mice in the colon at 
6 weeks of age were minor, obvious differences in 'H2A.X staining frequency and 
intensity of crypt epithelial cells were found in the ileum of IKK2caIEChom mice (Fig. 
23a and 23b). Nuclei of IKK2ca-expressing IECs exhibited a speckled staining 
pattern for 'H2A.X that is characteristic upon focal DNA damage. Since mice at this 
age also display some signs of ileal inflammation, increased levels of 'H2A.X in the 
ileum of IKK2caIEChom mice could be indicative for more DNA damage due to ROS 
that are produced under inflammatory conditions.  
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Figure 23   Higher levels of #H2A.X positive nuclei and increased number of $SMA expressing 
myofibroblasts in the intestine of IKK2caIEChom mice 
a. Slightly increased levels of 'H2A.X positive nuclei in the proximal colon of 6-week-old IKK2caIEChom 
mice. 
b. Higher numbers of 'H2A.X positive nuclei in the small intestine of 6-week-old IKK2caIEChom mice 
compared to age matched control animals. 
c. Increased amount of #SMA-expressing activated stromal fibroblasts in the intestine of young and 
aged IKK2caIEChom mice. 
Scale bars represent 50 $m 
 
The spontaneous intestinal tumour occurrence in aged IKK2caIEChom mice therefore 
most probably results from DNA-damage associated mutations in onco- and tumour 
suppressor genes in IECs, increased activation "-catenin and a concomitant increase 
in proliferation and maybe an alteration in the status of stem cells. Finally the 
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generation of a tumour promoting microenvironment composed of activated immune 
cells and stromal fibroblasts sustain and support epithelial tumour development. 
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4. Discussion 
 
4.1 What is the role of constitutive IKK2/NF-!B activity in the intestinal 
epithelium? 
The NF-!B signalling pathway is believed to play a major role in tumour 
development, since it regulates expression of genes involved in cell survival, 
proliferation and inflammatory responses (Karin, 2006). NF-!B has been proposed to 
act in tumour cells themselves, where it confers resistance to apoptosis and 
enhances proliferation. Indeed, many primary cancers as well as cancer cell lines 
display not only increased but also constitutive activation of NF-!B (Prasad et al., 
2010). In cells of the tumour microenvironment NF-!B acts to promote inflammation 
through transcriptional upregulation of inflammatory mediators that act like growth 
factors on tumour cells and thereby sustain tumour growth (Coussens and Werb, 
2002; Greten et al., 2004). Due to these diverse functions exerted by NF-!B 
transcription factors, the NF-!B pathway has been proposed to link inflammation and 
cancer (Karin, 2006).  
 
Indeed, multiple studies illustrated that activation of NF-!B is important for tumour 
development and controls basic processes required for carcinogenesis. For instance, 
IKK2 deletion in myeloid cells reduced the expression of tumour growth supporting 
cytokines and growth factors and thereby reduced tumour development in the 
AOM/DSS mouse model of carcinogen-initiated inflammation-driven colon cancer 
(Greten et al., 2004). Furthermore the activation of NF-!B in cancer-associated 
fibroblasts was shown to be important for skin carcinogenesis by coordinating the 
expression of fibroblast-derived proinflammatory factors promoting macrophage 
recruitment, neovascularisation and tumour growth (Erez et al., 2010). These reports 
underscore the importance of NF-!B in the promotion of carcinogenesis by acting in 
cells of the tumour micronevironment to induce the production of factors supporting 
tumour growth.  
 
The role of NF-!B activation in tumour cells is less clear. IKK2 deletion in epithelial 
cells reduced the incidence of AOM/DSS-induced colon cancer (Greten et al., 2004) 
and N-methyl-N-nitrosourea (MNU) induced gastric cancer (Sakamoto et al., 2010), 
which is in line with the pro-survival functions of NF-!B. Moreover, inhibition of NF-!B 
by expression of an I!B# supper-repressor (I!B#-SR) or by ablation of p65/RelA in 
lung epithelial cells reduced the incidence of oncogene-induced lung cancer 
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(Basseres et al., 2010; Meylan et al., 2009). The aforementioned reports therefore 
imply that NF-!B activity in tumour cells contributes to tumour development. 
However, inhibition of NF-!B in cells of the skin or the liver had opposite effects in 
different models of carcinogenesis. Expression of I!B#-SR in epidermal keratinocytes 
synergized with oncogenic Ras to induce epidermal cancer (Dajee et al., 2003), or 
even led to spontaneous tumour development (van Hogerlinden et al., 1999). On the 
other hand ablation of IKK2 in melanocytes was protective from oncogenic Ras 
induced melanoma development (Yang et al., 2010).  
 
Similarly, NF-!B blockade in hepatocytes through the expression of I!B#-SR in the 
Mdr2-deficient mouse model inhibited inflammation-associated liver cancer 
development (Pikarsky et al., 2004). In contrast, deletion of IKK2 in hepatocytes 
sensitized mice to chemical diethylnitrosamine (DEN) induced hepatocarcinogenesis 
(Maeda et al., 2005), and deletion of NEMO/IKK' specifically in liver parenchymal 
cells even resulted in spontaneous development of hepatocellular carcinomas in 
mice (Luedde et al., 2007). 
 
These findings show that NF-!B signalling exerts a very complex role during 
carcinogenesis in pre-malignant cells and that the outcome of NF-!B signalling 
depends on the tissue and the cancer model applied. These results also indicate that 
NF-!B activation in pre-malignant or tumour cells in addition to its very well-known 
anti-apoptotic functions is likely to affect different processes fundamental for 
carcinogenesis. Thus, it is not clear at which stage during tumour development NF-
!B activation is crucial and whether the activation of NF-!B per se is sufficient to 
drive cancer development. 
 
Experimental evidence presented in this thesis supports the idea that – at least in the 
intestine – NF-!B activation contributes to tumourigenesis already in pre-malignant 
cells and that NF-!B activation in tumour cells is sufficient to initiate all the necessary 
processes needed for tumour maintenance. Indeed, intestinal epithelial cell restricted 
expression of constitutively active IKK2 strongly enhances tumourigenesis in 
chemical and genetic intestinal cancer models in mice. Moreover, IKK2ca expression 
in IECs is sufficient to alter intestinal homoeostasis through IEC intrinsic and 
paracrine functions exerted by the microenvironment, which triggered inflammation 
and tumour development both in the colon and the small intestine. 
 
By inducing the expression of various inflammatory cytokines and chemokines, 
epithelial IKK2/NF-!B activation caused the recruitment and activation of 
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inflammatory cells, contributing to a mucosal microenvironment that supports and 
sustains intestinal carcinogenesis. However, it is remarkable that although IKK2ca 
expression induced strong activation of NF-!B signalling in IECs, only a subset of the 
known NF-!B-regulated cytokines and chemokines were induced. IL-6 for instance, 
which is a well-known NF-!B-inducible cytokine and has been implicated in colorectal 
carcinogenesis (Becker et al., 2004; Bollrath et al., 2009; Grivennikov et al., 2009), 
was not expressed at higher levels in IKK2caIEChom mice. Yet, TNF and to a lesser 
extent IL-1" were upregulated in both the SI and colon of IKK2caIEChom mice. These 
factors were most probably implicated in IKK2ca-mediated intestinal tumour 
development since they have been attributed important roles in regulating intestinal 
inflammation and carcinogenesis (Dinarello, 2010; Popivanova et al., 2008). The 
most highly upregulated gene in IKK2ca-expressing IECs in the colon and the small 
intestine was Ccl20, a chemokine that has been reported to induce tumour cell 
growth and migration in human colorectal cancer (Ghadjar et al., 2009). Cxcl-16, 
which has been suggested to promote inflammation-associated tumour development 
together with its receptor Cxcr6 was also highly induced in the intestine of 
IKK2caIEChom mice (Darash-Yahana et al., 2009). Therefore, the expression of IKK2ca 
in IECs induces the production of specific cytokines and chemokines with important 
pro-tumourigenic activities. 
 
Already at young age, these inflammatory mediators caused an increased 
abundance of inflammatory cells in the colonic and small intestinal mucosa of 
IKK2caIEChom mice. Constant activation of the IKK2/NF-!B pathway in IECs mainly 
resulted in recruitment of innate immune cells, such as F4/80-postitive macrophages 
and Gr1-positive granulocytes. In the small intestine macrophages and also 
granulocytes tended to accumulate around the crypt base, which is the region where 
the stem cells and the TA cells are located. Since it has been reported that intestinal 
tumours originate from crypt stem cells (Barker et al., 2009), increased myeloid cell 
infiltration in this area is likely to contribute to the spontaneous intestinal tumour 
development in IKK2caIEChom mice by creating a tumour-supportive 
microenvironment. In addition to increased myeloid cell numbers, IKK2caIEChom mice 
exhibited an accumulation of myofibroblasts in the colon. Through the secretion of 
growth factors, activated #SMA-positive fibroblasts play an important role in tumour 
growth (Franco et al., 2010). Activation of fibroblasts is mediated by inflammatory 
cytokines, such as IL-1" and TGF-" (Erez et al., 2010), both of which were 
expressed in intestinal tissue from IKK2caIEChom mice, indicating that IKK2ca-
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expression in IECs not only increases the number of mucosal innate immune cells 
but also activates stromal fibroblasts.  
 
These IKK2ca-mediated alterations together constituted a state of intestinal 
inflammation, which eventually resulted in tumour growth in the colon and the small 
intestine. Epidemiological studies have revealed that chronic inflammation is a major 
risk factor for cancer (Karin, 2006), and this notion was confirmed in mouse models 
of intestinal tumourigenesis. For instance, in the AOM/DSS-induced intestinal cancer 
protocol DSS-elicited colitis promotes tumour development initiated by AOM-induced 
DNA mutations, whereas AOM applied alone induces cancer at lower incidence 
(Neufert et al., 2007; Tanaka et al., 2003). Persistent inflammation can lead to cancer 
development also in the absence of prior carcinogen exposure. IL-10 deficient mice, 
for instance, suffer from spontaneous chronic colitis (Berg et al., 1996; Kuhn et al., 
1993) that led to colorectal cancer formation in 60% of 6-month-old IL-10-/- animals 
housed under SPF-conditions (Berg et al., 1996). Furthermore, Mucin2-/- animals, that 
displayed subclinical intestinal inflammation, develop spontaneous lesions 
throughout the intestinal tract (Velcich et al., 2002; Yang et al., 2008). These studies 
show that inflammatory processes can be a sufficient driving force for intestinal 
tumourigenesis, suggesting that altered intestinal immune homoeostasis in 
IKK2caIEChom mice could lead to the development of tumours in the intestine. 
 
Interestingly, the observed difference in tumourigenesis incidence between the small 
and the large intestine with a prevailing occurrence of adenomas in the colon of 
IKK2caIEChom animals is reminiscent of a similar situation in human patients, where 
tumourigenesis occurs more frequently in the colon (Vallabhapurapu and Karin, 
2009). Apart from inflammation, which appeared to be more severe in the colon, the 
difference in bacterial load could provide an explanation for this phenomenon. The 
amount of commensal bacteria is higher in the colon when compared to the small 
intestine (Wells et al., 2010). Indeed, bacteria can have a tumour promoting effect in 
inflammation mediated colon cancer models. For instance, AOM-induced tumour 
incidence decreased dramatically in germ-free IL-10 deficient mice, providing 
experimental evidence that bacteria are essential for inflammation and 
carcinogenesis. Furthermore, deletion of MyD88 in IL-10-/- mice prevented AOM-
mediated tumourigenesis, underscoring the importance of bacterial signalling for 
cancer development (Uronis et al., 2009). Also human commensal bacteria were 
shown to induce tumour formation in mice through activation of Stat3 and Th17 
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signalling (Wu et al., 2009). These studies show that in the absence of commensal 
bacteria tumour incidence is greatly diminished, suggesting that increased 
tumourigenesis in the colon could indeed result from a higher bacterial load. 
However, whether commensal bacteria are an important driving force for adenoma 
fromation in IKK2caIEChom mice could only be addressed if IKK2caIEChom animals were 
housed under germ-fee conditions, in which intestinal bacteria are absent. Also 
treatment of IKK2caIEChom mice with antibiotics could help to understand the impact of 
commensal bacteria in tumour development in these mice. 
 
Though the above-mentioned data point towards a crucial role of inflammation for 
tumourigenesis in IKK2caIEChom mice, there are studies suggesting that inflammation 
alone is unlikely to be sufficient for initiating intestinal tumourigenesis. For instance, a 
mouse model suffering from severe Crohn’s disease like chronic ileal inflammation 
caused by increased TNF expression was not sufficient to induce intestinal tumours 
(Kontoyiannis et al., 1999). This indicates that high levels of TNF and the 
inflammatory mediators induced by TNF do not suffice to induce tumour growth.  
 
More direct indications that IKK2ca-induced inflammation by itself might not be 
sufficient to explain tumour development in IKK2caIEChom mice comes from studies 
overexpressing IKK2 in other organs. For instance, high levels of IKK2 expression in 
the skin led to the spontaneous development of an inflammatory skin disease with 
similarities to interface dermatitis (Page et al., 2010). Though disease was chronic 
and progressed in severity, IKK2-transgenic mice did not develop skin tumours, 
indicating that increased levels of IKK2 and concomitant inflammatory disease are 
not sufficient to trigger cancer development in the skin. 
 
Furthermore, temporarily induced expression of constitutively active IKK2 in 
pancreatic acinar cells resulted in spontaneous development of acute pancreatitis 
(Baumann et al., 2007) associated with increased production of inflammatory 
mediators and immune cells infiltration. However, this temporal increase in activation 
of NF-!B signalling in pancreatic acini did not lead to tumour development. 
Therefore, persistent activation of IKK2 in the pancreas disrupts tissue homeostasis 
and induces an inflammatory condition that is not sufficient for driving 
tumourigenesis.  
 
These observations might suggest that inflammation per se is not enough to induce 
tumour development in the intestine of IKK2caIEChom mice. However, it might also 
point to an intestine-specific pro-tumourigenic cell-intrinsic effect of IKK2 activation. 
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In this respect, intestinal tumourigenesis is mostly associated with mutations leading 
to activation of the Wnt-signalling pathway (Pinto and Clevers, 2005). Wnt-signalling 
controls normal epithelial homoeostasis and mutations activating this pathway cause 
intestinal tumours in humans and mice (Barker and Clevers, 2000; Clevers, 2006; 
Fodde and Brabletz, 2007). Various mouse models of intestinal tumourigenesis that 
heterozygously express truncated versions of the tumour suppressor Apc have been 
established. Upon loss of the heterozygous wild-type Apc allele, "-catenin 
accumulates and activates transcription of Wnt target genes. This results in aberrant 
IEC proliferation and intestinal tumour growth in these mice. However, also 
carcinogenesis driven by AOM depends on mutations in components of this pathway, 
since mutations causing stabilisation of "-catenin, the central player of Wnt-
signalling, are frequently found in AOM-induced tumours (Greten et al., 2004; 
Takahashi and Wakabayashi, 2004).  
 
4.2  Cooperation between Wnt- and NF-!B signalling in intestinal tumour 
development 
IKK2caIEChom mice developed many tumourous lesions in the colon after a mild 
AOM/DSS regimen that did not induce any tumours in control mice. Considering the 
high sensitivity of IKK2caIEChom mice to DSS-induced colonic inflammation, an 
increase in tumour load upon AOM/DSS treatment in these mice most probably 
results from increased colitis and associated tissue damage. However, IKK2caIEChom 
mice also exhibited increased tumourigenesis in an AOM-induced colon cancer 
model that does not depend on inflammation mediated tumour promotion (Neufert et 
al., 2007). Therefore, DSS-induced mucosal injury is not necessary to drive AOM-
induced tumourigenesis in IKK2caIEChom mice. Nevertheless we showed that young 
IKK2caIEChom mice already suffer from inflammatory intestinal disease and produce 
higher amounts of proinflammatory mediators than control animals. Therefore, also 
AOM-induced tumour development in the intestine of IKK2caIEChom mice could 
partially result from ongoing inflammation that is absent in IKK2casFL mice. 
 
Since activating mutations in "-catenin are a common outcome of AOM treatment, 
enhanced AOM-induced tumour development observed in IKK2caIEChom mice could 
also be caused by cooperation between Wnt- and IKK2-mediated signalling in 
intestinal tumourigenesis. 
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A strong tumour promotive effect exerted by IKK2ca in Wnt-induced intestinal tumour 
development in Apc1638N/IKK2caIEChet mice provided more direct evidence for 
cooperation between these pathways. Not only did polyp formation in the small 
intestine occur much earlier in Apc1638N/IKK2caIEChet than in Apc1638N/IKK2casFL 
mice, there was also a shift in tumour localisation towards the colon. While in 
Apc1638N mice colon lesions are very rare and only occur in aged mice (Fodde et 
al., 1994), all Apc1638N/IKK2caIEChet mice analysed at 4 months of age had at least 
one colon tumour. Tumourigenesis in Apc mutant mice depends on loss of the wild-
type Apc allele. The increased tumour incidence in Apc1638N/IKK2caIEChet mice 
could be explained by a more frequent loss of wild-type Apc in 
Apc1638N/IKK2caIEChet versus Apc1638N/IKK2casFL mice.  
 
Taken together the data presented herein point towards a synergistic effect between 
Wnt- and IKK2/NF-!B-signalling in intestinal epithelial cells that contributes to tumour 
development in chemical as well as genetic models of intestinal cancer in mice.  
 
4.3  Impact of IKK2ca-expression on "-catenin stability and activity in IECs  
In support of an effect of IKK2ca on Wnt signalling, IKK2caIEChom mice expressed 
higher amounts of nuclear as well as active "-catenin protein in IECs. Higher levels 
of the "-catenin target gene Sox9 were identified by immunohistochemical staining in 
IECs from IKK2caIEChom than IKK2casFL mice, indicating that the transcriptional 
activity of "-catenin in these IECs was enhanced. Interestingly, Sox9 acts as a 
negative feedback regulator of "-catenin/Tcf4 and thereby prevents the expression of 
a subset of "-catenin target genes (Mori-Akiyama et al., 2007). Increased production 
of Sox9 in IKK2ca-expressing IECs therefore could provide an explanation for the 
fact that some "-catenin/Tcf4 target genes, such as c-myc and cyclin D1, were not 
increased in IECs from IKK2caIEChom mice (see Fig. 20). These observations suggest 
that expression of IKK2ca in IECs initiates a complex regulatory transcriptional 
network. In fact, the picture becomes even more complicated when one considers 
that NF-!B activation in chondrocytes represses Sox9 (Murakami et al., 2000). This 
might indicate either that increased "-catenin activity in IECs overrules the inhibitory 
function of NF-!B on Sox9 expression, or that inhibition of Sox9 transcription by NF-
!B could be cell type specific and might not occur in the intestinal epithelium.  
 
Nevertheless, since in vitro experiments suggested IKK2 rather to exert a negative 
regulatory effect on "-catenin activity, it is surprising that IKK2ca expression in IECs 
enhanced the activation of "-catenin and resulted in increased expression of at least 
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some of its target genes. IKK2 expression in murine embryonic fibroblasts (MEFs) 
and COS cells repressed "-catenin mediated transcription (Jensen et al., 1964; 
Lamberti et al., 2001). Furthermore, NF-!B activity in colon, liver and breast cancer 
was proposed to inhibit "-catenin activation by inducing the expression of Izts2 
(leucine zipper tumour suppressor 2), a molecule interacting with "-catenin and 
regulating its nuclear export (Cho et al., 2008). Therefore, our results point towards 
alternative mechanisms leading to the accumulation of this protein. It has been 
reported that robust activation of "-catenin in colon cancer cells requires additional 
cues apart from Wnt-ligand stimulation or Wnt-activating mutations (Rasola et al., 
2007; Vermeulen et al., 2010). For instance, growth factors such as HGF and PDGF 
have been proposed to induce transcriptional activity of "-catenin through initiating 
PI3K/Akt signalling. Indeed, Akt-mediated phosphorylation of GSK3" was shown to 
decrease degradation of cytoplasmic "-catenin (Fukumoto et al., 2001; Kaler et al., 
2009b; Korkaya et al., 2009). In addition, through phosphorylation of Serine552 of "-
catenin, Akt induces its nuclear translocation and transcriptional activation in 
intestinal epithelial cells (Fang et al., 2007). Although growth factors are expressed in 
high amounts by stromal myofibroblasts (Pietras and Ostman, 2010), which are 
present in the intestine of IKK2caIEChom mice already at young age, the possible link 
between increased epithelial "-catenin activity and growth factor induced Akt 
activation in these mice remains to be investigated.  
 
Furthermore, it has been reported that cytokines secreted by infiltrating immune cells 
can regulate activation of "-catenin in epithelial cells. Macrophages were shown to 
activate "-catenin in colon and gastric tumour cells by producing IL-1" and TNF 
(Kaler et al., 2009a; Kaler et al., 2009b; Oguma et al., 2008). Whereas macrophage 
derived TNF activated Wnt-signaling by inducing GSK3" phosphorylation in an NF-
!B independent manner, IL-1" activated "-catenin via NF-!B-dependent induction of 
PDK1/Akt-mediated GSK3" phosphorylation. In addition, also activation of "-catenin 
by progastrin-induced GSK3" phosporylation relied on IKK activation (Oguma et al., 
2008; Umar et al., 2009). Therefore constitutive activation of IKK2/NF-!B in the 
intestinal epithelium might mediate stabilisation of "-catenin by inducing inhibitory 
phosphorylation of GSK3" by Akt. These studies suggest that IKK2ca might achieve 
accumulation of "-catenin either in a paracrine way, by acting on cells of the 
microenvironment, or in a cell intrinsic way acting directly on PDK1/Akt signalling.  
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Another possible cell intrinsic mechanism by which IKK2ca expression could lead to 
stabilisation of "-catenin in IECs is by limiting the capacity of the "-TrCP E3 ubiquitin 
ligase. Since "-TrCP is required for degradation of both "-catenin and I!B proteins, 
high expression levels of IKK2ca in IECs might induce continuous degradation of I!B 
proteins and thereby reduce availability of "-TrCP for "-catenin degradation.  
 
In line with the knowledge that the Wnt-signalling cascade is responsible for 
maintaining the proliferative capacities of the intestinal epithelium, we observed an 
increased amount of proliferating (Ki67 positive) IECs in the intestine of young 
IKK2caIEChom mice. In IKK2caIEChom mice Sox9-expressing, proliferating and therefore 
not terminally differentiated colonic IECs were extended towards the apical region of 
crypts. Also in small intestinal crypts the number of Sox9 positive cells was increased 
when compared to controls. This enhanced proliferative activity likely contributed to 
the tumour prone phenotype of IKK2caIEChom animals. 
 
4.4  Effect of IKK2ca-expression in IECs on intestinal epithelial stem cells 
In addition to epithelial proliferation, the Wnt-signaling pathway also regulates the 
fate of intestinal crypt stem cells, which are the cells of origin of intestinal cancers 
(Barker et al., 2009). We observed that all cells in the base of SI crypts, which in wild-
type mice harbour few Ki67 positive stem cells and terminally differentiated Ki67 
negative Paneth cells, stained strongly with Ki67 antibodies in IKK2caIEChom mice. 
Furthermore, immunohistochemical staining for Sox9 in crypt bases of the small 
intestine from IKK2caIEChom mice did not allow the clear identification of Paneth cells 
or stem cells as in control crypts. These observations suggested that the stem cell 
compartment in IKK2caIEChom mice either exhibits an increased proliferative activity or 
cells from the TA compartment are extended towards the crypt base.  
 
An alteration in stem cell status was indicated by increased transcription of stem cell 
associated factors in the intestine of IKK2caIEChom mice. Some of the stem cell 
associated factors transcribed at higher levels in IKK2caIEChom mice contained NF-!B 
binding sites in their promoters, such as CD44, Olfm4, and Bmi-1 (Chin et al., 2008; 
Dutton et al., 2007; Hinz et al., 2002). Furthermore we identified a conserved NF-!B 
binding site in the proximal promoter region of Ascl2, suggesting that expression of 
this transcription factor could be under the control of NF-!B. However, since CD44 
and Ascl2 are "-catenin/Tcf4 target genes (Sansom et al., 2004; van der Flier et al., 
2009), increased "-catenin activity in IKK2ca-expressing IECs could contribute to the 
      Discussion 
 97 
elevated expression of these factors. Since IKK2ca upregulated Ascl2 expression in 
HCT116 cells, human colon carcinoma cells that contain a point mutation in "-catenin 
leading to its constitutive activation (Gayet et al., 2001), elevated IKK2/NF-!B activity 
might synergize with "-catenin to increase Ascl2 expression. Similarly, the hyaluronic 
acid receptor CD44 that is produced by not terminally differentiated epithelial crypt 
cells is a target gene of both NF-!B and "-catenin/Tcf4 (Hinz et al., 2002; van de 
Wetering et al., 2002; van der Flier et al., 2009).  
 
In contrast to CD44 and Ascl2, Olfm4 expression is regulated in a "-catenin-
independent manner (van der Flier et al., 2009) and is induced by NF-!B in gastric 
cancer cells (Chin et al., 2008; Kim et al., 2010). Therefore high amounts of Olfm4 in 
the colon of IKK2caIEChom mice most probably result from increased NF-!B activity. 
Since expression of Olfm4 is elevated in the intestinal epithelium of IBD patients 
(Shinozaki et al., 2001), high levels of Olfm4 mRNA could result from inflammation in 
the colon of IKK2caIEChom mice. Also Bmi-1 is an NF-!B target gene that so far was 
not shown to be under the transcriptional control of "-catenin/Tcf4 (Dutton et al., 
2007; van der Flier et al., 2009), suggesting that its upregulation in small intestine 
from IKK2caIEChom mice might be solely due to enhanced NF-!B activation. 
 
Lgr5 (Gpr49), the currently most widely accepted marker for crypt base columnar 
stem cells, is a Wnt target gene and its expression was furthermore shown to depend 
on Ascl2 (Barker et al., 2007; van der Flier et al., 2009). Although both Ascl2 mRNA 
and "-catenin protein were present at higher levels in the intestinal epithelium of 
IKK2caIEChom mice, Lgr5 mRNA was not increased in the intestine of these mice. The 
forecited inhibition of "-catenin activity by Sox9 (Mori-Akiyama et al., 2007) could 
provide a possible explanation for this observation. Alternatively, high levels of 
IKK2/NF-!B activity might impair Lgr5 expression by a so far unknown mechanism. 
Intestinal tissue from IKK2caIEChom mice also displayed higher mRNA levels of DLK1, 
a factor that prevents differentiation of cultured IECs and has been assigned a role in 
tumour development (Dong et al., 2004; Guda et al., 2007). Increased expression of 
DLK1 in IKK2caIEChom mice might contribute to their sensitivity for intestinal 
tumourigenesis. 
 
The altered expression of stem cell associated factors in IKK2caIEChom compared to 
IKK2casFL mice indicates that constitutive activation of IKK2/NF-!B in the intestinal 
epithelium either directly, through cell intrinsic mechanisms, or indirectly, through 
paracrine functions, affects the stem cell compartment. 
      Concluding Remarks 
 98 
5. Concluding Remarks 
The data presented in this thesis show that epithelial restricted expression of 
constitutively active IKK2 in the intestine is sufficient to induce and sustain chronic 
intestinal inflammation and subsequent tumour development in mice. Expression of 
IKK2ca rendered pre-malignant IECs capable to induce all the cell-intrinsic and 
microenvironmental changes that are necessary for tumourigenesis, suggesting that 
persistent activation of IKK2/NF-!B, at least in the intestinal epithelium, can play a 
causative role in tumourigenesis. A recent report identified an amplification of the 
IKK2 locus in different human cancers by large-scale unbiased genomic analysis of 
somatic copy number alterations, suggesting that also in human cancers activation of 
NF-!B in tumour cells could play a direct role in tumour development (Beroukhim et 
al., 2010).  
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